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ABSTRACT
Unnecessary, preventable death from asthma has been widely
reported. This thesis examines the management of two groups of
asthmatics, one admitted to hospital and the other cared for in
the community, to determine the extent of under-treatment of
asthma.
In a prospective study of 157 acute asthma cases reviewed at home
13 days after hospital discharge, at least 34% had symptoms of
poor asthma control. Subgroup analysis showed that under-use of
corticosteroids (p = 0.04) and of peak flow measurements in
assessment (p<0.005), and a failure to increase inhaled therapy
at the time of discharge (p<0.005) or to review patients
subsequently (p<0.005), were associated with a greater likelihood
of continuing symptoms (p = 0.03). In hospital practice,
therefore, suboptimal management was found to be commonly
associated with excess morbidity.
In community practice a sample of 701 asthma attendances to a
group of practitioners was compared with 81 attendances over the
same period to a single practitioner with a special interest in
asthma.
The interested practitioner used inhaled corticosteroids more
often (p<0.005) and long term oral steroids less (p<0.05). If
therapy was changed this practitioner preferred to increase
inhaled therapy (68%) whereas others tended to give antibiotics
for increased asthma symptoms (56%) . The interested
practitioner used corticosteroids as second line therapy whereas
i
for other practitioners steroids were the fourth and least likely
treatment option, after antibiotics, oral bronchodilators or an
increase in inhaled therapy.
After the controlled introduction of an asthma management
programme to half of the survey population of practitioners and
patients there was an increase in the use of inhaled
corticosteroids, as judged from repeat prescriptions (p<0.001).
In addition antibiotics were used less often (p<0.05) and there
was an upward trend in the use of oral corticosteroids in this
group only.
Asthma management is therefore shown in both these settings to
vary considerably and in the hospital group such variations are
associated with differences in outcome. A programme of
information and discussion has been assessed and shown to




NATIONAL MORBIDITY SURVEY DATA FOR ASTHMA AND ASSOCIATED
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CHAPTER 1 - INTRODUCTION AND REVIEW OF THE LITERATURE
(i) Evidence for increasing morbidity and mortality from asthma
The epidemiological study of asthma has been hampered by a lack
of agreement on its definition (Gross, 1980). British
physicians have stopped short of using the American Thoracic
Society's definition (1962), which includes reference to the
presence of bronchial hyperreactivity as a cardinal feature and
concentrate rather on clinical evidence of variability in airflow
obstruction as the main characteristic (Scadding, 1977).
Ideally this should be recorded objectively by spirometry or peak
flow rate measurement, but, particularly in general practice this
may not always be feasible.
With this caveat in mind, recent evidence has been presented
(Fleming, 1987) suggesting, in common with anecdotal accounts
(Morrison - Smith, 1979), that the prevalence of asthma is
increasing. National morbidity surveys have been carried out in
general practice in 1955-56, 1970-71 and 1981-82. These latter
two surveys covered a population of 300,000, with 19 practices
participating in both, and a further 31 in 1970-71 only and 27 in
1981-82 only. Patients and consultations for specified
conditions including asthma were recorded throughout each year.
Comparison of the 1970-71 and 1981-82 figures shows an
approximate doubling of the annual prevalence of asthma in
both males and females (Table 1). By comparing the number of
people diagnosed as suffering exclusively from asthma, hayfever,
acute and chronic bronchitis it can be seen that there were
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increases in the numbers with asthma and hayfever, while figures
for acute bronchitis increased slightly and those for chronic
bronchitis fell. Separate analysis of the results from the
19 practices participating in both surveys, minimising
confounding variations in topography, weather and population
characteristics showed close agreement with the total survey
data.
The authors' remark on the decline in chronic bronchitis which
they have seen in their own clinical practice, and whilst it
remains possible that some patients previously considered to have
exclusively chronic bronchitis are now considered to have
exclusively asthma (and not some combination of both) even such a
major swing would not account for the increase in numbers with
asthma. The authors, therefore, conclude that the increase in
asthma prevalence is not simply due to a change in diagnostic
preference by practitioners.
This work, taken with the original 1955-56 morbidity survey,
which found an annual period prevalence of asthma of 8.5/1,000
registered population, therefore, shows a continuing upward
trend, (Figure 1) to 20.0/1,000 per males and 15.9/1,000 per
females.
Other evidence also suggests that morbidity from asthma is
increasing. There are upward trends in the sales of inhaled B
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CHANGES IN ICD CODING. RELATING TO THE CLASSIFICATION OF ASTHMA
DEATHS
Revision Period Condition Named on
Death Certificate
ICD Code to Which
Death Assigned
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In England and Wales hospital discharge rates for asthma have
increased from 6.8 per 10,000 in 1975 to 11.2 per 10,000 in 1981
(DHSS/OPCS 1974-83). In the national morbidity surveys already
described the increase in referrals to hospital (excluding self
referrals) was almost entirely due to an increase for emergency
admission (Table 3). Social Security claims for absence from
work due to asthma have doubled from 1968 to 1982 (Ayres, 1986).
Finally and perhaps most significantly, this increase in various
parameters measuring asthma morbidity has been associated with an
upward trend in asthma mortality in this country.
Asthma mortality rates for 15 - 44 year olds over the past thirty
years are shown in Figure 2 overleaf. The International
Classification of Diseases (ICD) has been revised three times
during this period so that deaths due to asthma, where bronchitis
is also mentioned, are now attributed to asthma (Table 4).
The effect of these changes can be judged from the Office of
Population, Censuses and Surveys (OPCS) bridge coding, whereby in
1967, before the introduction of the 8th revision of ICD and in
1978, before the introduction of the 9th revision, death
certificates were coded by both outgoing and incoming revision
rules (Table 5 overleaf) (Stewart, 1985).
As can be seen, this change in coding has only a minimal effect
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TABLE 5
BRIDGE CODINGS IN TRANSITION YEARS TO SHOW THE EFFECT OF ICD
REVISIONS (STEWART. 1985)
Age Death assigned to asthma
(years) in 1967* 1 1978+













































1 401 +28 i
* all asthma deaths.
+ 25% sample of asthma deaths.
Parentheses indicate percentage based on small number of
observations.
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FIGURE 3: EFFECT ON CHANGES IN ICD CODING ON STANDARDISED ASTHMA
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ACCURACY OF DEATH CERTIFICATION
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A further factor which influences mortality rates is the accuracy
of death certification. This was assessed in the initial stages
of a survey of asthma deaths performed by the British Thoracic
Association (1982). A total of 153 certificates containing the
word asthma were forwarded to these investigators, of which 101
would have been coded by the 9th revision of ICD as asthma
deaths. Detailed case note review and interviews with
attending practitioners and close relatives of the deceased
resulted in the panel deciding unanimously that death was due to
asthma in 89 of these cases (88%). Again analysis by age showed
the smallest error in certifications to occur in young adults
(Table 6).
Bearing in mind the effects of changes in ICD coding and the
accuracy of death certification, Burney's (1986) analysis of
asthma mortality rates shows an increase (see Figure 2) which is
due particularly to an increased mortality rate in 5 - 34 year
old males (Table 7 and Figure 4 overleaf). Concern over
increasing asthma mortality rates has also come from New Zealand
(Jackson, 1982) and the United States (Sly, 1984) suggesting that
this may be a more widespread phenomenon (see later).
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TABLE 7
ASTHMA DEATH RATE PER MILLION POPULATION AND STANDARDISED
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* ICD 8th revision, all other figures ICD 9th revision.
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(ii) Preventable factors shown in most asthma deaths
Several surveys of deaths from asthma have been reported in the
past decade in the United Kingdom. In these the circumstances
of over 400 deaths from asthma have been investigated.
Cochrane and Clark (1975) identified 21 deaths in hospitals in
Greater London and reviewed the treatment given. They found
that in seven of these cases corticosteroids had either not been
used or given in only minimal doses; that in at least half of all
cases objective assessment of airflow resistance or measurement
of arterial gas tensions were not performed and finally that a
majority (70%) both of this group and a further group of
19 survivors of an acute asthma admission had been treated with
sedatives.
Macdonald (1976a) investigated 53 hospital deaths in Cardiff.
He confirmed the above findings on the underuse of
corticosteroids, measurement of peak flow rates or blood gases
and commented on a tendency for doctors and patients to
underestimate the severity of the fatal attack.
In a further study of 90 deaths in the community
(Macdonald, 1976b) the fatal attack occurred in patients with a
long history of asthma (mean 16 years). 92% had had previous
hospital admissions with severe asthma and 21% had been in
hospital within two months of death. Although in that group the
fatal attack was typically shortlived, Arnold (1982) assessed the
speed of onset of asthma attacks in 26 surviving cases and showed
no relationship with severity of the full developed episode.
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Bellamy (1979) assessed previous asthma symptoms in 44 acute
asthma admissions to hospital and found that patients had poorly
controlled wheeze for an average of five weeks before admission,
which was finally precipitated by more rapid deterioration.
These findings suggest that a proportion of Macdonald's cases
(1976b) may have had longstanding poor asthma control.
Ormerod (1980) reviewed 38 deaths outside hospital and 15 in
inpatients in Birmingham. In the community cases, 60% had
previously been admitted to hospital and 16% died within three
weeks of discharge. 37% saw their practitioners early in the
fatal attack but in no case was a significant change in therapy
made. In the final stages under-treatment persisted and
arrangements for hospital admission were made for only two of
11 patients alive when the practitioner arrived.
The 15 hospital deaths also occurred predominantly in patients
with longstanding asthma. Most (13) had had previous
admissions. Their initial pulse rates were in the range
88-120/minute. Two had peak flow rate and four arterial gases
measured initially but in no case was this subsequently
monitored.
As already mentioned, the British Thoracic Association (1982)
reviewed the circumstances of 90 deaths from asthma in the West
Midlands and Mersey regions in 1979. All but eight of these
cases had had asthma for at least five years and 58 (65%) had a
previous hospital admission for acute asthma, 19 within the last
year of life. Thirty eight patients (42%) were under forty five
16
years of age and 62 (69%) were taking corticosteroids regularly
in some form. Detailed review of patient and treatment
characteristics led the panel of three physicians to judge that
53% of patients were not fully co-operative in their management,
that patients, their relatives and doctors often failed to
recognise the severity of asthma with delay in starting
appropriate treatment and that corticosteroids and
bronchodilators were underused. In all, preventable factors
were thought to have contributed to 86% of these deaths.
Cochrane (1975) had noted a significant excess of deaths
occurring in the early morning. This was not confirmed in the
Cardiff (Macdonald 1976a) or Birmingham (Ormerod, 1980) series
suggesting a possible link with the high proportion of his cases
who were receiving sedatives. However, in a later analysis of
sudden deaths of asthmatics in hospital (Hetzel, 1977) a majority
occurred between midnight and six a.m. Whilst admission
tachycardia, the presence of over 20 mm Hg of pulsus paradoxus,
low peak flow rate or hypokalaemia failed to predict these
patients, in all cases abnormally large swings in diurnal peak
flow variation (>50%) were seen. Such a degree of variability
of peak flow rate was seen in 30% of all cases, but nevertheless
correlated strongly with the risk of ventilatory arrest and
sudden death.
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Thus regular recording of peak flow rate not only provides
objective assessment of response to treatment, but it can also
alert the physician to the profound degree of airflow obstruction
which some patients experience in the early morning, which places
them at great risk.
The recent new epidemic of asthma deaths in New Zealand
(Jackson, 1982) prompted the establishment of an MRC Asthma Task
Force in Auckland (Sears, 1986). Study of 147 asthma deaths
there in parallel with the BTA investigation confirmed all the
preventable factors described by the BTA to be present in
Auckland, although there was a higher rate of non-preventable
deaths in New Zealand, suggesting a greater severity of asthma
there.
A subsequent case control study (Rea, 1986) has also been
reported. Hospital and community controls for 44 acute asthma
death cases under the age of sixty were found. The cases were
more likely than community controls to have severe disease
(relative risk 4.1), a hospital admission (relative risk 16.0) or
visit to an emergency department within the previous year
(relative risk 8.5). Only two factors, however, distinguished
those who died from surviving hospital controls. These were the
occurrence of previous attacks of life threatening asthma
(defined as attacks with disturbance of conscious level or raised
PCO2) (relative risk 3.8) or the existence of psychosocial
problems (relative risk 3.5). This term was used to describe
recent bereavement or unemployment, or evidence of alcoholism,
personality disorder or depression described in the case notes.
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In all other measures of severity of attack, treatment and
supervision, cases dying and hospital controls were similar.
A further retrospective analysis of hospital deaths from asthma
(Eason, 1987) in which controls were matched for age, sex and
admitting hospital, but not severity of asthma has recently been
reported. Again defects in management, as far as these can be
judged in a retrospective study were identified not only in 83%
(29/35) cases but also in 40% (14/35) of controls.
Thus every survey of asthma deaths reported over the past twelve
years (1975 - 1987) has identified preventable factors to have
contributed to many of these deaths. Both patients and their
doctors have been shown to underestimate the severity of asthma,
with under-treatment preceding death. That the latest of these
surveys (Eason, 1987) shows little improvement to have occurred
despite the widespread coverage these articles have received
(Editorials in Thorax, 1978; Lancet, 1979; BMJ, 1979) is highly
disturbing.
19
(iii) Other evidence of underdiagnosis and under treatment of
asthma
Many workers have highlighted the common occurrence of wheeze in
childhood, with increased recognition that the differentiation of
wheezy bronchitis from asthma is spurious (Williams, 1969).
In a sample of 284 nine year old Croydon school children, a third
of those with disturbed nights or restricted activity due to
wheeze had taken no anti-asthma drugs in the past month
(Anderson, 1981). Both this and another survey of 7 year old
school children (Lee, 1983) showed a cumulative prevalence of
asthma or episodic wheeze of 11%. Speight (1983) assessed 179
school children who had had at least one episode of wheeze in the
preceding two years, since school entry. All but 14 had seen
their general practitioners, but a diagnosis of asthma had been
made in only 21. Bronchodilators had seldom been given in the
absence of such a diagnosis. This study found that use of the
word asthma with explanations and effective treatment led to
parental relief, and not anxiety.
A later survey of childhood asthma in a single practice
(Levy, 1984) also found a prevalence of 11%. These authors,
however, noted that in half of the cases, at least 16 attendances
with respiratory symptoms occurred before such a diagnosis was
made.
20
Comparable cross-sectional surveys of adults with asthma are more
difficult to perform. As the prelude to assessment of a
specified management plan in a practice population of 13,000
(Modell, 1983) 115/170 asthmatics identified from the practice
disease register as having current asthma were assessed. Sixty
eight of these were over fifteen years old. Fifty six per cent
of this subgroup of adult asthmatics had respiratory symptoms at
least once per week, 44% had a single random peak flow recording
more than four standard deviations from their predicted normal
and 33% had had more than five units of disability in the past
four months. (One unit of disability = half-day spent in bed or
chair, one day lost from usual activity or two days of reduced
activity). All these findings indicate the substantial burden
that asthma can impose.
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(iv) Doctors' and patients' understanding of asthma
One of the preventable factors cited in the previous discussion
of asthma deaths was the tendency of both doctors and patients to
underestimate the severity of asthma, and to under-react.
The views of both doctors and patients on various aspects of
asthma management have been examined. In general they confirm
the above impression.
Henry (1983) compared the responses to 25 questions on the
management of childhood asthma of 26 paediatricians and
21 physicians with an interest in chest medicine. These
questions aimed to explore specialist practice rather than text
book knowledge and reflected the questions that parents often
ask. There were considerable differences in opinion for over
half of the questions. The authors' comment on the problem that
parents and general practitioners face when given different
advice from several different sources.
Marks (1983), using a series of ten statements about asthma,
asked 78 general practitioners and 7 consultants with an interest
in childhood asthma to express agreement or disagreement on a
scale of 0 - 7. Age, practice characteristics and teaching
commitments of the practitioners were also obtained. There was
significant disagreement between these two groups of doctors on
nine of the ten statements. Trainers and practitioners teaching
medical students regularly showed fewer disagreements than
other practitioners. The chief areas of disagreement suggested
that a sizeable minority of practitioners were unaware of the
22
TABLE 8
CHARACTERISTICS OF ASTHMA CLINIC PATIENTS SURVEYED FOR
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* 8 patients admitted at least once with acute asthma.
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i
less stereotyped ways in which childhood asthma may present and
were pre-occupied with recurrent respiratory tract infection and
its treatment. Both of these conclusions were echoed by
Levy (1984).
Patients too have been shown to have widely disparate views of
their condition often despite well-intentioned attempts to inform
them.
50 chronic asthmatics in Aberdeen (Ellis, 1985) were questioned
on their reactions to an attack of asthma, awareness of the
potential seriousness of their condition, knowledge and use of
drugs. Their characteristics (Table 8) show them to have severe
disease. Nevertheless they were ill-informed and complacent.
34% never sought medical help during any attack and only 20%
recalled ever being given advice on what to do if an exacerbation
of symptoms occurred.
During a moderate to severe attack, 72% would delay seeking help
for at least forty eight hours, even if current therapy were
ineffective, a reluctance to call out their practitioner at night
forming an important element of this.
Most patients did not recognise the serious prognostic
implications of certain features of their disease, notably the
occurrence of nocturnal symptoms and 28% did not believe
that anyone ever died of asthma. These findings were confirmed
by another Highland study (Franklin, 1987).
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Attempts at improving patient awareness and self management
skills in the UK have met with little documented success.
Hilton (1986a) reported the results of a controlled evaluation of
the effect of patient education on asthma morbidity. Three
groups of asthmatics (a control group and groups receiving a
limited and maximum education programme) were assessed by means
of a questionnaire. There was a significant improvement in
knowledge only in the group receiving the maximum education
programme but neither of the two "educated" groups showed any
difference in self management skills or asthma morbidity compared
with the control group.
Modell (1983), in the previously mentioned assessment of a
management plan concentrated on discussion, explanation and
education of asthmatics in a single general practice. A
research assistant interviewed 92 asthmatics beforehand and a
year later. Despite recorded adherence to the management plan
by all attending practitioners many patients (42%) still felt
they did not know enough about asthma, or thought the doctors'
explanation was inadequate (48%). Many (32%) were not taking
treatment as advised. Some improvement in the indices of asthma
morbidity recorded was seen, namely a reduction in the number of
disability days (see earlier definition) in the past four months,
an increased proportion of patients with a random peak flow
measurement in the normal range and a reduction in the proportion
with asthma symptoms more than once weekly. Nevertheless major
discrepancies between the doctors (often intuitive) assessment
and that of the researcher who spent over an hour with each
patient suggested that such underestimation of severity of
25
disease by practitioners remained a major bar to the proper use
of available therapy.
More intensive health education programmes, often administered by
professionals and aimed at more severely affected asthmatics have
been shown to produce improvements in morbidity and self
management skills in the United States (Fireman, 1981;
Maiman, 1983). These have tended to use behavioural techniques,
teaching a new response to an old problem rather than aiming to
improve knowledge in a diffuse way, suggesting that this may be a
more useful technique (Hilton, 1986b).
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(v) Conclusions
All the available evidence, therefore, suggests that asthma, a
common condition, is increasing in prevalence and the associated
mortality may be rising in parallel. Sales of most of the drugs
commonly used to treat asthma are also rising in the UK.
Nevertheless, unnecessary deaths continue to occur and, at least
in children, preventable morbidity has been documented.
All the literature on deaths from asthma is retrospective, and
may not reflect on other cases of asthma who survive. For these
two reasons a prospective survey of hospital management of acute
asthma was carried out, and linked with measures of outcome to
enable objective conclusions to be made.
A large scale survey of current asthma management in general
practice was also performed as a prelude to the introduction of a
programme of advice and information for practitioners, and to a
lesser extent, for patients.
27
CHAPTER 2 - A RETROSPECTIVE SURVEY OF HOSPITAL ASTHMA MANAGEMENT
SUMMARY
A retrospective survey of asthma admissions to general medical
units during 1983 was made. One hundred and twenty seven cases
occurred, of whom 52 were males (44%). The average age was
45.2 years. Forty eight per cent were receiving inhaled steroids
or cromoglycate before admission and 16% regular oral steroids.
Initial assessment seldom included peak flow measurement
although these were made subsequently in 57%. No steroids were
used in 32% of cases. No oxygen was given in 48% of cases and
when used was usually at low flow rates. Apart from a reducing
course of steroids, 46% of cases were discharged with no increase
in pre-admission maintenance treatment and although follow-up was
planned for 76% it was for an average 4.9 weeks later. This
survey suggested widespread under-treatment and under-supervision
of asthma patients admitted to acute general medical wards,
similar to the findings of surveys of asthma deaths.
INTRODUCTION
As discussed in the previous chapter, asthma is increasingly
common, and the associated mortality, particularly in young men
is also rising. Preventable factors have been shown to
contribute to many deaths.
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Mortality from asthma probably represents the tip of an iceberg
of morbidity, which is more difficult to measure. Patients with
acute asthma are in an unstable phase of their disease and are a
high risk group. To investigate how their management conformed
to accepted standards, a pilot retrospective survey of asthma
admissions to a single teaching hospital in 1983 was made.
METHOD AND PATIENTS
Glasgow Royal Infirmary provides acute medical services to the
east end of Glasgow, with a catchment population of 190,000.
Four medical units receive emergencies for twenty four hour
periods by rotation, a majority of the patients being admitted
initially to an acute receiving ward. The case notes of all
patients admitted in 1983, for whom a diagnosis of asthma was
recorded on the discharge code were scrutinised. All recorded
details of each patient's age, sex and past history were
extracted from the notes using a checklist. Details of
assessment on admission, initial treatment and subsequent
supervision, both in hospital and after discharge were also
collated.
Results are given as percentages of number of episodes or
patients, as appropriate, and statistical analysis was by Chi
square testing, with Yates correction for continuous variables.
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RESULTS
The discharge coding identified 165 admissions, but only 127 of
these proved on closer scrutiny to have been admissions primarily
for deteriorating asthma. Of the remaining 38 cases who were
excluded from subsequent analysis; 21 had quiescent or
co-incidental asthma, or no evidence at all of asthma; 11 cases
had been transferred shortly after admission to a specialised
chest unit at an adjacent hospital; three records were
untraceable and three died. None of these deaths was due to
acute asthma; one occurred in an elderly man in Type II
respiratory failure with no previous history of asthma, one in a
patient treated initially for asthma but found at bronchoscopy to
have tracheal obstruction by a central tumour, and the third in
an asthmatic patient who developed abdominal sepsis after a
routine cholecystectomy.
1 Demographic and Other Descriptive Data
The 127 admissions occurred in 118 patients, 110 patients having
one admission, seven patients two admissions and one patient
three admissions within the year. There were 52 males (44%).
The age range was from 14 - 80 years, mean 45.2 years, median
51 - 60 years. Forty eight (40%) patients were described as
having had asthma since childhood, 54 (46%) late onset asthma and
this was a new diagnosis on admission in 12 patients (10%).
Duration of asthma was not specified in five patients. At the
time of admission 61 cases were lifelong non-smokers (48%),
36 (28%) current smokers and 23 (18%) ex-smokers. No record of
smoking history was made in seven cases (6%).
30
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In 61 (48%) cases inhaled steroids or cromoglycate were being
taken before admission. Twenty (16%) cases were receiving
regular oral steroids before admission but of these only two were
also taking inhaled steroids, cromoglycate or both.
There was no apparent cause for deterioration found in 54 cases
(42%). Viral illness or upper respiratory tract infection
(15 cases) and chest infection (24 cases) were the commonest
cited quoted cause (30% together). Other reasons for admission
are shown in Table 9. The mean length of stay in hospital was
5.8 days.
2 Initial Assessment and Treatment
Pulse and respiratory rate were always recorded, together with
blood pressure, when first seen. The pulse rate was over
110 bpm in 57 cases (45%) although respiratory rate was recorded
at over 30 per minute in only 31 (24%) of cases. Pulsus
paradoxus was looked for in 21 cases (16%) , and was present in
12 of these. Peak flow rate was recorded on admission in
11 cases (9%). Every record had a comment on cyanosis. It was
said to be present in 33 cases (25%). Blood gas analysis was
performed on admission in 55 cases (43%), the p02 being less than
60 mmHg in 19 of these cases. However, the inspired O2
concentration was seldom quoted in conjunction with blood O2
tension, so that it was impossible to evaluate most of the
results.
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Forty eight (38%) cases were treated with intravenous steroids
and 80 (63%) with oral steroids, 39 receiving both of these.
IV aminophylline was given in 50 cases (39%) so that overall
32 cases (25%) received all three treatments. Thirty six cases
(28%) received none of these three forms of treatment.
Nebulised bronchodilator, given in every case, is the standard
form of immediate treatment in this hospital, often as the
patient is initially assessed. Oxygen was recorded as having
been given in 66 cases (52%) and of these only 19 received 35% or
higher concentration O2. Intravenous fluids were given to 10
(8%). There was significant correlation (X^ = 170.14,p <0.01)
between admission pulse rate and increasing intensity of
treatment given (oral, iv steroid + aminophylline), such that
those with the highest pulse rates were most likely to receive
all three modalities, and those with lowest pulse rates least
likely.
3 Supervision in Hospital and After Discharge
After admission to the wards regular peak flow recordings,
usually before and after bronchodilator were made in 72 cases
(57%) and a comment was made on the adequacy of inhaler technique
in 27 (21%). Thirty three cases had blood gas analysis
performed after admission (compared with 55 in admission and 66
given O2) and 40 (31%) had full pulmonary function tests
performed. There was no correlation between admission pulse
rate and increasing level of supervision as judged by these
parameters. Of 80 given oral steroids, all but three were
discharged on these (60% of all cases). In 54, instructions to
reduce and withdraw steroids were adequately detailed in the case
33
TABLE 10
LONG TERM CHANGE IN TREATMENT AFTER DISCHARGE
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notes, in nine this was not mentioned and 14 had been
instructed to maintain steroids until reviewed as outpatients.
Apart from a reducing course of steroids, longer term changes in
treatment were made in 70 cases (61%), as shown in Table 10.
Arrangements for follow-up were made in 97 cases (76%), most
patients being referred to or followed-up at a respiratory clinic
(78/97, 80%), with appointments planned for a mean of 4.9 weeks
later.
DISCUSSION
This study describes the population of asthmatics treated in a
single general hospital over the period of one year. It shows
the range of severity of asthma and of treatment given. The
population described is similar in many respects to that of the
BTA report on asthma deaths (1982). (BTA report 43.7% males
against 45% in this study; BTA group 42% under 45 years, mean age
45.2 years here; BTA group 68.9% taking oral or inhaled steroids
or DSCG, this series 62%.)
Bearing in mind the limitations of retrospectively acquired data,
factual elements liable to have been recorded in all cases were
emphasised. The accuracy of this data was maximised by the
crosschecking of medical information with drug prescription cards
and nursing notes. The small number of cases seen in one year,
although similar to that reported by others, (Crompton, 1979) may
reflect a tendency for asthma in adults, especially but not
exclusively if smokers, to be diagnosed as obstructive airways
disease (Dodge, 1980 and 1986).
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The obverse of many of these findings is as important as the data
as presented. In over 90% of admissions no objective assessment
of airflow obstruction was made before treatment was started,
echoing the findings of other workers (Reed, 1985).
Fifty seven per cent had subsequent PEFR recordings made; on what
basis the assessment of improvement of the remaining 43% was made
is not clear, particularly when this is liable to have involved
several individuals over a period of time. It was not possible
in a retrospective survey to make a clinical assessment of
severity of asthma (Jones, 1971), which has however been shown to
correlate well with objective parameters including pulse rate
(Arnold, 1982). This being the case it is noteworthy that there
was a significant correlation between admission pulse rate and
increasing intensity of treatment, but other findings suggest
that treatment was suboptimal.
Sixty eight per cent of patients were treated with some form of
steroids in addition to bronchodilators, leaving 32% with asthma
sufficiently severe to require inpatient treatment but not with
this most effective form of treatment. Although Luksza (1982)
suggested that giving steroids did not influence the rate of
recovery from an acute attack of asthma it is standard
respiratory practice (Clark, 1983). Corticosteroids are potent
anti-inflammatory agents and also restore B adrenergic receptor
responsiveness (Ellul Micallef, 1975; Shenfield, 1975), thus
improving the bronchodilator effect of inhaled B agonists. Most
respiratory physicians would agree with Grant's view (1982)
that to withhold such treatment can be dangerous.
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Half of all cases were treated with oxygen and when this was
given it was used at low concentration, inappropriate in acute
asthma, and often not monitored by subsequent blood gas analysis.
In forty six per cent no provision was made for an increased
level of maintenance therapy. Follow-up was planned, rather
than definitely arranged, for most (76%) but not until five weeks
later on average, despite the fact that the period immediately
after hospital discharge can be an unstable and dangerous one for
the asthmatic (Macdonald, 1976(b); Ormerod, 1980).
This pilot study, therefore, showed that the management of a
proportion of asthmatics may have differed from standard
respiratory practice and confirmed that further investigation was
worthwhile.
In particular it was necessary to be certain firstly that all
admissions for acute asthma had been included and secondly that
some assessment of outcome was made, so that any differences in
management could be objectively assessed.
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CHAPTER 3 - PROSPECTIVE SURVEY OF ACUTE ASTHMA MANAGEMENT IN
HOSPITAL
SUMMARY
One hundred and fifty seven (81%) acute asthma admissions to a
single hospital over a calendar year were surveyed prospectively
by interviewing patients at home on average 13 + 6.4 days after
discharge and by reviewing their case records for details of
hospital management.
Significant proportions of cases were poorly controlled at
interview with 34% reporting regular sleep disturbance due to
wheeze, 50% morning chest tightness and 49% wheeze climbing one
flight of stairs.
On admission patients were described as having symptoms of
deteriorating asthma for a median three days. Closer
questioning of half of the cases (n=71), however, revealed that
70% had had regular symptoms of poor asthma control for weeks or
months.
The findings, therefore, that only 73% were treated with oral
corticosteroids, that 47% had regular maintenance therapy
increased at the time of discharge and that review was planned
for 68% on average 3.5+2 weeks later suggest that
under-supervision and under-treatment of asthmatics is not
confined to cases dying from asthma.
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INTRODUCTION
The pilot survey of hospital asthma management described in
Chapter 2 suggested that under-treatment and under-supervision of
asthmatics was occurring in a proportion of cases, and may not be
confined to patients dying of their disease (BTA, 1982 and
others). A prospective survey of all acute asthma admissions
was therefore undertaken, with patients being seen at home
shortly after discharge, so that their progress following the
index attack could be monitored.
METHOD
With the support of the hospital's medical division, all cases of
acute asthma, and episodes of wheezing illness in non smokers
were identified from day to day by close liaison with the medical
and nursing staff of the admitting wards. Four medical units in
the hospital receive emergencies by rotation. Patients reported
by the admitting firm to belong to these two categories were then
invited to take part in the survey, the nature of which was
described. Arrangements were made to visit participating
subjects at home approximately two weeks after discharge. The
patients' general practitioners' agreement was obtained at this
stage. In the patient's home, a checklist of some 40 items (see
Appendix 1) was completed in a semi-structured interview. This
provided a detailed description of each patient's asthma history
and previous treatment; of events leading up to the hospital
admission; management in hospital and immediately after
discharge; of current symptoms of asthma; understanding of their
condition and associated drug therapy. This interview usually
took between 20 and 30 minutes. After an interval of
approximately two months, the patients' case notes
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were then reviewed and details of assessment of asthma severity,
management and supervision culled from them.
All this information was stored on a VAX-VMS mainframe computer
and further data analysis made using SPSS-X.
RESULTS
(1) Exclusions
One hundred and ninety four cases were enrolled in the study.
One hundred and fifty seven cases were followed up as described,
giving an overall follow-up rate of 81%.
The 37 cases not followed up as described were accounted for as
follows. Three deaths occurred (2 males) in patients with an
average age of 66 years. Nine cases were transferred within
24 hours to an adjacent chest unit and were not included because
most of their management was undertaken there. (However, a
further 12 cases who were transferred to the same unit an average
of five days after admission were followed up and included in the
analysis below.) Nine patients were not seen at home as
arranged and failed to respond to subsequent telephone call or
letter. Four patients from outwith Glasgow were not contacted.
Three patients were re-admitted to other hospitals before
interview and six admissions occurred in two vagrants, often
largely for social reasons. Finally, there were three cases
where follow-up was not possible or inappropriate for medical
reasons; in one case the general practioner refused permission
for follow-up, in another the patient was confused with
co-existing cerebrovascular disease and a third was transferred
to long term geriatric care.
40
TABLE 11
BASIS OF DIAGNOSIS OF ASTHMA
1 1
| Clear history + objective evidence |








| Doubtful history, but previous +ve |
i steroid trial and evidence of j












(2) General Details of History
One hundred and fifty seven admissions occurring in 139 patients
over a full calendar year were investigated. Sixteen patients
had two admissions and one had three admissions. The average
age (+ one standard deviation) of the patients was
47.9 + 19.9 years. Seventy per cent were non smokers (lifelong
non smokers 41%, ex smokers 29%), 30% current smokers.
Survey of the entire hospital record of the patients, augmented
where appropriate by review of their asthma clinic attendance
records shows the basis on which the diagnosis of asthma was made
(Table 11). Thus 62% had objective evidence of reversible
airflow obstruction from these records, a further 24% a clear
history of episodic wheeze typical of asthma, and only 11% a
doubtful history of wheeze and no confirmatory lung function
results. Six patients who had been found at this stage of the
investigation to have evidence in their case notes of non
reversible airflow obstruction, usually on the basis of a
previous trial of steroids, were excluded completely from the
analysis described here.
Ninety per cent were on some form of asthma therapy before
admission, with inhaled B2 agonists the commonest form of
treatment (85%) (Table 12 overleaf). Sixty one per cent were on
long term asthma therapy as detailed in Figure 5. Of those
taking regular inhaled steroids or cromoglycate, 28% admitted
that they remembered to take the full daily dose on less than
five days out of seven. Only 13% had an arrangement to start
oral corticosteroids if their asthma deteriorated, with an
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REGULAR TREATMENT BEFORE INDEX ADMISSION
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average starting dose of 31 mg (range 5-60 mg). Thirty two
per cent gave a history of having had a sudden (developing within
one hour) severe (not helped by inhalers and requiring medical
attention) attack within the past three years. The median value
for previous admissions to hospital with asthma was 1 (range
0-50, with 12 patients recalling an undefined large number of
admissions). The median number of attendances to their general
practitioners in the preceding year with exacerbations of asthma
symptoms was 3 (range 0-12, four patients recalling an undefined
large number). Thirty six per cent were attending a hospital
asthma clinic and 26% attended their general practitioner
regularly, these groups not being mutually exclusive.
(3) Events Leading to Hospital Admission
On average patients reported their asthma to have been
deteriorating for a median 3 (range 0-42) days before admission;
38% described increasing symptoms for less than 24 hours. This
compared well with information recorded in the hospital case
notes, where patients were said to have had deteriorating asthma
for a median (range) of 3 days (0-42) before admission, apart
from 11% (18 cases) in whom poor asthma control was recorded for
"weeks" before admission. On questioning patients closely it
became clear, however, that many patients had been poorly
controlled for a long time and were describing a "final straw"
phenomenon (Arnold, 1982). This was formally assessed in the
last 71 subjects, and showed that only 30% had truly episodic
symptoms, while 10% had had regular symptoms of poor asthma
control for weeks and 60% for months before hospital admission.
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Forty five per cent of cases sought help from their general
practitioners at the onset of the episode leading to hospital
admission and for 91% of these some change in treatment was made.
Sixty six per cent of those whose treatment was changed at that
stage were given antibiotics, 44% a course of oral
corticosteroids and 17% oral bronchodilators, some cases
receiving more than one of these.
Immediately before admission 56% of all cases were seen by either
their regular or emergency GP service and 26% of all cases were
given some therapy before admission, parenteral theophylline
being the commonest drug used.
(4) Hospital Assessment and Management
The average pulse rate on admission to hospital was
110 + 19 bpm, 43% of cases having a pulse rate >110 bpm. Only
13% had peak flow rate recorded as part of initial assessment
although 54% had subsequent recordings made. Seventy four per
cent had arterial gases analysed, in 38% of these p02 was
<60 mmHg.
All patients received nebulised bronchodilators regularly during
their hospital admission. A course of oral corticosteroids was
given to 73% of cases, with 20% receiving no steroid at all.
When steroids were to be continued after discharge the average
daily dose of prednisolone on discharge was 18 mg. Twenty one
per cent of cases were given a bolus and 9% an infusion of
aminophylline. Sixty one per cent were treated with
antibiotics. Of 60% who received oxygen, only 27% of this
subset were treated with high flow (at least 35%) oxygen.
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Sixty one per cent of patients reported that their use of an
inhaler had been checked in hospital but only 20% remembered
being given some explanation of their drug therapy.
Thirty three per cent reported no change in previous therapy at
the time of discharge, and this was confirmed from their case
records. The dose of oral or inhaled therapy or both was
reduced in a further 20%. Hospital review was planned for 68%
of cases, an average of 3.5 + 2 weeks later.
The diagnosis recorded on the discharge summaries of the
157 admissions is shown in Table 13. As can be seen, in only
53% of cases was this recorded for the general practitioner and
future hospital reference as acute asthma, despite the fact that
all cases were reported by medical and nursing staff as patients
with asthma or wheezing illness in non smokers. Furthermore 86%
had either previously recorded reversible airflow obstruction or
were lifelong smokers with episodic wheeze (Table 11).
(5) Patients' Understanding of Asthma and Treatment
In view of the possibility that an earlier interview may have
influenced patients' subsequent understanding of therapy, details
relating only to first admissions (n=139) are included in this
section.
81% of cases felt they would recognise a bad attack of asthma in
the future, but this was usually on the rather non specific basis
of increasing wheeze and chest tightness. Only 7% spontaneously
mentioned sleep disturbance, 4% increased bronchodilator usage
and 13% decreasing efficacy of inhaled bronchodilators as
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* Includes some patients finishing a short course of oral
steroids.
[ ] indicates small absolute numbers.
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specific warning signs of a severe attack. Sixty three per cent
said they would either call their doctor in an emergency or go
straight to hospital, or vary this depending on severity of the
attack, and 34% had no such appropriate plan of action in the
event of a further attack. Although 13% on specific questioning
had arrangements to start a course of oral steroids, only
2 patients (1%) volunteered that this would be their response to
a further attack.
As shown in Table 14 many patients had no idea how their drugs
worked, in particular whether they could expect some benefit
within minutes (inhaled bronchodilators and Atrovent), hours
(theophyllines, oral bronchodilator) or after prolonged use
(inhaled and oral steroids, DSCG).
(6) Current Asthma Control
Thirty four per cent of cases reported regular sleep disturbance
since hospital discharge, 50% regular morning chest tightness
requiring them to use their bronchodilator before rising from bed
and 49% wheeze climbing one flight of stairs.
Seventy seven per cent of cases had inhaler technique judged as
either good or fair. Technique was judged to be good for the
device being used if it was being used correctly. For the most
commonly used metered dose inhaler this required that
co-ordination was good, the patient made a long inspiratory
effort and held his breath at the end (53%). Technique was
described as fair (24%) if any of these elements was suboptimal,
but a reasonable part of the dose had been inhaled.
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DISCUSSION
No such prospective survey of hospital asthma management has
previously been reported. Eighty one per cent of all asthma
admissions to a single hospital over a calendar year have been
included. Assessments, in the patients' homes, were all
performed by a physician with previous experience of managing
asthma. The group as a whole had clear histories and a majority
had objective evidence of reversible airflow obstruction and were
thus to be clearly differentiated from patients with an
exacerbation of chronic bronchitis and minor associated wheeze.
The group surveyed clearly had moderately severe asthma, with 61%
receiving long term inhaled or oral corticosteroids. In this
respect they were broadly similar to the BTA group of 90 asthma
death cases (1982), of whom 69% were taking such treatment.
Several characteristics of the patients themselves deserve
mention. Only 13% had been instructed to start a course of oral
steroids if a further severe attack occurred but an even smaller
proportion (2%) mentioned steroids specifically when asked what
they would do in this event. Only a handful of cases had peak
flow meters to use at home although 32% gave a history of sudden
severe attacks. Compliance of the group was fair as far as this
was judged with 72% of those on long term inhaled steroids or
cromoglycate reporting taking their full dose at least five days
per week. Less than half had been to see their general
practitioner in the course of the index attack, a common reaction
of patients being that such attacks were something which had to
be tolerated and would settle with time. Indeed 34% had no
appropriate plan of action in the event of a further attack.
Most patients had little understanding of the way in which their
drugs could be expected to help.
51
/
These observations are similar to surveys of asthma clinic
attenders in Aberdeen (Ellis, 1985) and Inverness-shire
(Franklin, 1987) and enlarge the BTA report findings (1982) that
many patients and not only those dying of asthma underestimate
their disease and delay calling help.
Asthma management is obviously individual both to patients and to
some extent to physicians. Broad generalities do, however,
exist and most respiratory physicians would probably agree that
acute asthma should be treated with high flow oxygen, nebulised
bronchodilators and oral corticosteroids, and that peak flow
measurements provide an important objective measurement of
airflow obstruction (Cushley, 1983). This survey describes
current management practice in general medical wards.
Less than half of cases had been started on steroids before
admission to hospital and 27% did not receive a course of oral
steroids in hospital. This compares with 37% not given such
treatment in both the pilot study (Chapter 2) and in a
retrospective survey in 1978 (Osman, 1987) . Where they were
used, adequate instructions about further dosage appeared to have
been given. Three symptoms were used of which (i) nocturnal and
(ii) early morning asthma were assumed to indicate poor asthma
control whereas (iii) exercise capacity gave a broader measure of
patient's current state at the time of interview. The large
proportion of patients with continuing symptoms of poor asthma
control 13 days after discharge suggests that corrective and
maintenance steroid therapy may have been inadequate.
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Both general and hospital practitioners continue to be
pre-occupied with bacterial infection as an underlying problem in
asthma, with 66% of patients given antibiotics at home and 61% in
hospital. This practice continues despite good evidence that
such treatment has no impact on the duration and severity of
asthma attack (Graham, 1982). Only a small proportion of cases
were treated with high flow oxygen (27% of those receiving O2)
and very few had peak flow measured as part of initial
assessment.
At least half of all cases had their previous regular treatment
unaltered or even reduced in the aftermath of an asthma attack
requiring hospital admission. This finding, together with the
discrepancy between the reported median 3 day increase in asthma
symptoms noted in the case records, compared with the 70% of
cases who admitted to symptoms of poor asthma control either for
weeks or months before admission, suggest that an inappropriately
short term view of the illness was being taken. The average
3.5 weeks to follow-up, of those given such an opportunity also
disregards the real possibility of symptoms recurring as the dose
of oral steroids declines, soon after discharge.
In summary this prospective audit of hospital asthma management
shows that asthma is often poorly treated in general medical
units, with inadequate attention being paid to the importance of
pre-existing poor asthma control, to the improvement of lung
function and therapy, and to the close subsequent supervision of
a group of patients in an unstable phase of their disease.
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Subgroup analysis of some aspects of the management of these
cases is discussed in the ensuing chapters, providing further
more specific evidence of problem areas.
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CHAPTER 4 - DIFFERENCES IN HOSPITAL ASTHMA MANAGEMENT BETWEEN
MEDICAL WARDS WITH A RESPIRATORY INTEREST AND OTHERS
SUMMARY
Full details including admitting ward were available on 77% (150)
of all asthma admissions in a prospective audit of hospital
asthma management. Cases could be subdivided into 64 admitted
to general wards with a respiratory input (Group R) and 86 to
similar wards without such specialist interest (Group G). Cases
in Groups R and G were similar in terms of age, previous severity
of asthma, previous treatment and initial pulse rate. Fewer
cases in Group G were treated with oral corticosteroids (R - 83%,
G - 67% p = 0.04), had regular peak flow recordings (R - 73%,
G - 42% p < 0.005) or were given return appointments (R - 92%,
G - 56% p < 0.005) and fewer had their regular inhaled therapy
increased after discharge (R -55%, G - 28%, p < 0.005). These
differences in management were associated with more cases from
Group G reporting sleep disturbance (R - 23%, G - 41% p = 0.03),
morning chest tightness (R - 37%, G -55% p = 0.03) or wheeze on
one flight of stairs (R - 34%, G -58% p < 0.005) at interview
thirteen days later. In addition 20% of cases first admitted to
medical wards with no specialist respiratory interest were re¬
admitted within the year compared with 2% of first admissions to
medical wards with a respiratory interest (p < 0.005). The
better outcome in Group R cases shows that their more intensive




The results described in the preceding chapter on the broad
generalities of management and follow-up of acute asthma cases
suggested underlying differences or inequalities in care. To
investigate this further differences which existed between
patients looked after in general medical units with a respiratory
physician attached and in other units with no such specialist
commitment were sought. That differences between such
categories of wards may exist was suggested by the observed
differences in asthma mortality rates between specialist thoracic
and general medical units (Crompton, 1979; Hetzel, 1977).
Furthermore, a retrospective survey of a random 25% of cases of
acute asthma in one region in 1978 had shown differences
particularly in the use of peak flow recording in hospital and
the prescription of inhaled steroids after discharge
(Osman, 1987).
In view of the arrangement of the medical units in the hospital
surveyed, which has two general medical units with a respiratory
input and two with no such commitment, subgroup analysis of these
two groups of cases in terms of previous history and treatment,
management of the acute attack and outcome was, therefore,
undertaken. This analysis was also possible because patients
had been seen at home without any knowledge of hospital
management and in particular without knowledge of the admitting
ward, so that the observations made at interview were effectively
"blind" to this aspect.
Statistical Analysis
Differences between groups were assessed by Chi squared analysis,
to test the null hypothesis of no observed differences.
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Case Control Analysis: Because there was a small difference in
average age of Group R and G cases (see later), cases admitted to
general medical wards with a respiratory input (R) were matched
with controls from general medical wards with no specialist
respiratory input (G) for three variables: (i) age, within ten
years; (ii) duration of asthma; (iii) pre-existing maintenance
treatment (none, inhaled or oral steroids or both). Differences
in management and outcome variables of these matched pairs were
analysed by the method of Breslow and Day (1981).
RESULTS
Of 157 asthma admissions included in the survey full details were
available for 150 (77% of all asthma admissions during that
year). These 150 cases are further considered here, subdivided
into cases admitted to two general medical units with a
specialist respiratory input (Group R) and two general medical
units without a specialist respiratory input (Group G). The
specialist respiratory input consisted on one chest physician
with three consultants with other interests, one middle grade
(registrar or senior house officer) staff member with a
commitment to respiratory medicine and residents who spent
approximately one of their six months working in a chest unit.
Thus although patients admitted as emergencies had a better
chance of being assessed by those with a special interest this
was not always the case in such wards.
There were sixty four (43%) cases in Group R and 86 (57%) in
Group G. Forty seven per cent of patients in each group were
males. Table 15 shows some characteristics of the two groups of
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PATIENT CHARACTERISTICS ON ADMISSION TO HOSPITAL
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1 1
|Number of cases admitted ]









± 20.4 * j
1 1





|No. (%) with clear history ± |
j PFTs (i + ii) j
|No. (%) with less certain |
| history ± PFTs (iii) |
|No. (%) with less certain |





















| 28 (44,28) * |
i i
|Number (%) on steroids, any |








|Average number previous |







± 8.1 * |
1 i
|Average number exacerbations j







± 3.9 * j
1 1
|Av. time symptoms increasing j







J ± 4.9 |
1 I
|Initial pulse rate |








* n = 57 n = 76
based on 1st admission only to avoid bias
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patients in terms of average age, previous severity of asthma,
previous treatment and initial pulse rate as a guide to severity
of the index attack.
Each patient, at the time of his case record review was
categorised on the certainty upon which a diagnosis of asthma was
made. Four categories emerged as follows:-
(i) patients with a clear history of episodic wheeze, whether
smokers or non smokers, with pulmonary function tests showing
reversible airflow obstruction;
(ii) patients with a clear history of episodic wheeze, but no
pulmonary function data available. All these patients were
lifelong non smokers;
(iii) patients with a less certain history of wheeze, often
smokers or ex smokers, but pulmonary function evidence of
reversible airflow obstruction;
(iv) patients with a less certain history of wheeze, often
smokers or ex smokers, and no pulmonary function results at all
in their notes.
The proportions of Group R and G cases in each category was
similar (Table 15) and in other respects the two groups of
patients were comparable. The small difference in average age
of patients was not significant at the 5% level and was not
associated with any other difference in previous treatment or
index of asthma severity (see later).
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| 2.5%, 29.5% |
|Antibiotics j 35 (55) 1 61 (71) | -31.5%, 0% |













|PEFR + spirometry j 47 (73)
1
| 36 (42) +
1 I
|15.9%, 46.1% |
|Blood gas analysis 50 (78) 1 65 (76) !
|Inhaler technique | 1 1 1
| assessed | 46 (72) 1 45 (52)* | 6.2%, 33.8% |
|Explanation of drug 1 1 1







|number (%) | 1 1 1
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|Chronic obstructive 1 1 !
| airways disease | 10 (16) 1 35 (42) + |-39.8%,-12.2%|




* p < 0.05 +p< 0.005
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Differences in hospital diagnosis, management and supervision are
shown in Table 16. Differences in treatment and supervision on
discharge from hospital and in outcome are shown in Tables 17 and
18.
Group R cases were significantly more likely to be treated with
oral corticosteroids with a trend, not reaching significance of
decreased use of antibiotics (Table 16). Group R cases were
also significantly more likely to have peak flow rates or
spirometry monitored (p < 0.005) although no difference between
groups in terms of the frequency of arterial blood analyses was
seen.
Significantly more Group R cases had inhaler technique checked
although in fact there was no difference in the proportions of
patients judged to have either good or fair inhaler technique at
interview. More Group R cases remembered being given some
explanation of the effect of drugs prescribed.
A highly significant difference (p < 0.005) was found between
proportions of cases with no planned review appointments,
(Table 17) although there was no difference in the planned
average time to review between Groups R and G for cases being
reviewed. Nevertheless a greater proportion of Group R had
review appointments within a fortnight of discharge (p < 0.025).
There were no differences between the groups in terms of changes
in oral therapy after discharge but a greater proportion of Group
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|No review planned j
| number (%) | 6 (9) 39 (44)* -47.6%,-22.4%|
|Average time to review,|
| if this planned (wks)| 3.3 ± 1.7 4.15 ± 2.2 !
|% of those with review |
| appointments having j
I appointment within
1 2/52 | 36 (21/59) 15 (7/47)+ 6.4%, 35.6% |
* p < 0.005 + p < 0.025
62
TABLE 18



















|Sleep disturbance | 15 (23) 35 (41)* 1-32.6%, -3.4%|
|Morning tightness j 24 (37) 47 (55)* |-33.8%, -2.2%|
|Wheeze on one flight j 1 1
| of stairs !
1 1
1 1








|No. (%) re-admitted j 1 1
| within survey year |
1 1
1 (2)+ 15 (20) 1 1
1 1
* p < 0.05 + p < 0.005
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All these differences between Groups R and G were associated with
significantly fewer symptoms reported by Group R of sleep
disturbance, morning chest tightness and wheeze on climbing one
flight of stairs at the time of interview (Table 18 overleaf).
In the course of the survey 17 patients had more than one
admission to hospital with acute asthma. Sixteen patients had
two admissions and one patient three admissions. Fifteen of the
17 patients (88%) were admitted on the first of their admissions
to medical wards with no specialist respiratory input. Thus 20%
of first admissions in Group G were re-admitted to hospital
within the year compared with 2% for first admissions in Group R
(Table 18) (p < 0.005).
Finally, there was a highly significant difference (p < 0.005) in
the proportions of cases described as acute asthma or an
exacerbation of chronic obstructive airways disease (COAD)
between Groups R and G (Table 16). This was the case despite
the fact that all cases were initially reported as acute asthma
or wheezing illness in non smokers. In addition the proportions
of cases in the various categories of diagnostic certainty for
asthma were similar for Groups R and G (Table 15), suggesting
that these diagnoses were being used indiscriminately in medical
wards with no specialist respiratory interest.
In view of the small, albeit non-significant, difference in age
between these two groups of cases, with older patients in
Group G, Group R cases were matched with suitable control G group
cases, as described in methods. This allowed a case control
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TABLE 19
CASE CONTROL ANALYSIS OF 51 MATCHED PAIRS (68% of sample)
Variable




1 Oral corticosteroids given 1 15,
1
5 | <0.05







3 Admissions coded as asthma,
as opposed to COAD 12,
1
1
2 I < 0.005
4 Sleep disturbance at
interview
Morning chest tightness




















Note the first number gives the
was present in R but not in G;
pairs the variable was present
number of pairs
the second is the




pairs oral corticosteroids were given to the patient in R but
not to the corresponding matched patient in G. In only five
pairs were they given to the patient in G but not to the one in
R. In the other 31 pairs both patients received the same
treatment.
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analysis to be undertaken on 51 matched pairs (68% of the
sample). The results of this analysis (Table 19) confirm the
previous findings since all parameters remained significant with
the exception that there was no significant discordance in the
matched pairs as regards those whose inhaled treatment was
increased at the time of discharge from hospital.
DISCUSSION
This analysis shows unequivocally that differences in hospital
management are occurring regularly and that such variations are
associated with difference in outcome, whether measured in the
short term (symptoms of poorly controlled asthma two weeks after
discharge from hospital) or long term (likelihood of re-admission
to hospital within the year).
Descriptive studies such as this do not allow the findings to be
related in a causal manner, although inferences may be made which
in a purely scientific environment could then be formally tested.
To use patients in this manner would not however be ethical.
Previous evidence, as discussed in Chapter 1, has suggested that
under-treatment and under-supervision of asthmatics is
potentially dangerous. The analysis presented in this chapter
shows as definitely as would be regarded by most to be ethically
reasonable, that underuse of oral and inhaled corticosteroids and
poor supervision in hospital and soon after discharge are
associated with excess, and by inference, preventable morbidity.
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The study was not designed to assess any excess mortality, for
which much greater numbers would have been necessary. Compared
with the small number of patients dying of asthma, however, the
problem of preventable morbidity in patients surviving an acute
asthma attack resulting in hospitalisation is much larger.
A retrospective random sample of asthma cases treated by
specialist thoracic and general physicians reported recently but
carried out in 1978 (Osman, 1987) also showed differences in
management similar to those described here. That similar
findings were made in 1986 shows that medical practice has not
substantially changed.
In summary, two historically similar groups of asthmatics, with
similar severity of the acute index attack have been managed
differently and a regime employing oral corticosteroids, regular
objective measurement of lung function to assess response,
greater use of inhaled therapy particularly inhaled
corticosteroids and close supervision after hospital discharge
has been shown to be superior in terms of both short and long
term outcome.
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CHAPTER 5 - HOSPITAL MANAGEMENT OF ASTHMATICS COMPARED WITH THOSE
GIVEN A DIAGNOSTIC LABEL OF "CHRONIC OBSTRUCTIVE AIRWAYS
DISEASE"
SUMMARY
The management of 46 asthma cases in whom the hospital discharge
diagnosis was Chronic Obstructive Airways Disease (COAD) was
compared with 85 cases with a final diagnosis of uncomplicated
asthma. The group labelled COAD were older (p < 0.005), more
likely to be male (p = 0.02), smokers or ex smokers (p < 0.005)
and less likely to have objective evidence of reversible airflow
obstruction recorded in their case notes (p = 0.03).
Nevertheless, more were taking inhaled and oral corticosteroids
before admission to hospital. No differences in the use of oral
corticosteroids, or antibiotics in hospital or in the use of
inhaled corticosteroids after discharge were observed between
those labelled COAD and asthma.
Fewer COAD cases had peak flow recordings made in hospital
(p < 0.005) or hospital review arranged (p = 0.03). At
interview a fortnight after discharge from hospital similar
proportions of "COAD" and asthma labelled cases reported symptoms
of poorly controlled asthma although more COAD cases described
wheeze on climbing one flight of stairs (p < 0.05).
This data suggests that asthma may be being underdiagnosed in
older males with a smoking history by failing to evaluate their
symptoms objectively or over time. Nevertheless, this group was




A subgroup of 46 cases (29%) out of the total of 157 admissions
for acute asthma or wheezing illness in non smokers had a final
diagnosis of COAD made. This chapter examines some differences
in background history, management and outcome between this group
and the larger group (85, 54%) with a final diagnosis of
uncomplicated asthma.
RESULTS
Table 20 shows the average age, sex ratio and initial pulse rate
of these two groups. Table 21 outlines various aspects of
previous treatment and severity of asthma and the proportions
giving a clear history of sudden severe attacks of wheeze, as
previously defined.
Table 22 shows the smoking history and details, from information
available in the hospital record, how firmly a diagnosis of
asthma could be made. Tables 23 and 24 outline some aspects of
hospital management and Table 25 follow-up and outcome. Each of
these areas will now be discussed, the layout being designed so
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1 1
p<0.01 |
* Data from first admissions only used to prevent bias.
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DISCUSSION
Cases labelled COAD were significantly older than others, and
more likely to be male. There was no difference in average
pulse rate on admission, showing at least an initial similarity
in the acute illness in these two groups. Pulse rate has been
shown to correlate closely with other clinical indices of airflow
obstruction such as breathlessness, ability to move or speak and
peak flow rate (Arnold, 1982). Significantly more cases
admitted to medical wards with no specialist respiratory input
received a discharge diagnosis of COAD compared with cases
admitted to medical units with such an interest. This was the
case despite the observation (Chapter 4) that the proportion of
cases with previously documented reversible airflow obstruction
were similar in these groups (Table 15).
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Similar proportions of COAD and asthma labelled cases were taking
B2 agonists and inhaled or oral corticosteroids before admission,
suggesting that a possible diagnosis of asthma had been
entertained equally in both groups in the past. There was no
difference in severity of disease, as judged by previous hospital
admissions or exacerbations of wheeze in the preceding year and
similar proportions described sudden attacks of severe wheeze
within the past three years. All these similarities suggest we
are dealing with not two but one homogenous group.
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TABLE 22
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* refers to first admissions only
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More of the COAD labelled group were smokers or ex smokers and
significantly fewer of this group had previously documented
reversible airflow obstruction. Thus of 14 cases in the whole
survey group with an uncertain history of intermittent wheeze,
and no pulmonary function results available (those with
documented irreversible airflow obstruction having been totally
excluded) 13 were labelled COAD. In these 13 cases such an
imprecise diagnostic label may have been correct. Nevertheless,
just under half of the COAD labelled group (19/46, 46%) had
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Oral corticosteroids were used with equal frequency in asthma and
COAD labelled cases, as were antibiotics. Intravenous
aminophylline was used more frequently in those subsequently
labelled asthma, as was high flow O2. Regular peak flow
recordings, or spirometry was monitored less often in COAD
cases.
Significantly fewer COAD labelled cases had their inhaled therapy
increased on discharge from hospital. This was associated with
a non-significant trend in favour of more asthma cases then
being treated with high dose inhaled corticosteroids (47% of
asthma, 28% of COAD labelled cases).
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TABLE 25
REVIEW ARRANGEMENTS AND OUTCOME
Asthma
Groun
1 COAD Group 1




No. (%) with planned
review appointments 64 (75)
1 1
1 1
1 25 (54) |
1 1
p<0.05
Average time to review
(weeks + ISD) 3.5 ± 1.9
1 1
1 1
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At interview a fortnight later, similar proportions of COAD and
asthma labelled cases reported regular sleep disturbance due to
wheeze or morning chest tightness - classic symptoms of poorly
controlled asthma. Considerably more COAD cases described
wheeze on one flight of stairs (p<0.05).
GENERAL DISCUSSION
All cases included in this survey were initially reported as
asthma admissions or as wheezing illnesses in non smokers. A
proportion were subsequently labelled COAD. The similarities
between cases finally labelled as COAD and asthma described here
suggest they belong to a single category; asthma therapy was
being used equally often, sudden severe wheeze was reported by
similar proportions and after discharge symptoms of poorly
controlled asthma were reported equally often. The differences
are of great interest - COAD labelled cases were older, male,
smokers or ex smokers and less likely to have documented
reversible airflow obstruction, or to have peak flow rates
monitored. They were less likely to be reviewed after discharge
and reported greater exercise limitation, despite broadly similar
treatment regimes to those labelled asthma.
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These observations are corroborated by a longitudinal survey of
respiratory morbidity started in Tucson, Arizona in 1976. This
has shown (Dodge, 1980 and 1986) that those over forty years of
age labelled as asthma, emphysema and chronic bronchitis report
similar symptoms and smoking histories. Detailed analysis of
their subjects suggests that gender is a major determinant of
diagnostic category with older males reporting wheeze, dyspnoea
and attacks of shortness of breath with wheeze likely to be
diagnosed as having emphysema and females with similar symptoms
as asthma.
The observation that oral corticosteroids were used with equal
frequency in COAD and asthma cases in this population and that
inhaled steroids were started or increased equally often suggest
that the differences in diagnostic label may be clinically
unimportant. This is at variance with Speight's finding (1983)
that in childhood asthma naming the condition as such was a major
determinant of giving specific anti asthma therapy. However,
the lesser use of peak flow readings to measure response to
therapy objectively, the tendency to discharge patients without
review and to label patients with proven asthma (as judged by
documented reversible airflow obstruction) with the less precise
portmanteau term "COAD" suggest that therapy may not have been
tailored to patients' needs. It may partially explain the
excess of such cases reporting marked exercise limitation due to
wheeze. Whilst this minor difference in outcome may be due to
inherent differences between the groups not otherwise identified,
it may also be due to differences in management which would fail
to detect reversible airways obstruction.
80
CHAPTER 6 - PATIENTS WITH MORE THAN A SINGLE ADMISSION DUE TO
ACUTE ASTHMA
SUMMARY
Historical details and management of 17 patients who had more
than a single admission with acute asthma during the course of
the survey were compared with the 61 patients who had a single
admission to medical wards with no specialist interest and 56 to
medical wards with a respiratory interest.
No differences in previous asthma treatment or severity of
asthma, or of the index admission were seen, and similar
proportions had a secure diagnosis of asthma.
Fewer of those subsequently re-admitted had inhaled
corticosteroids increased (or started) on discharge from hospital
(p <0.005) and the median dose of prednisolone on discharge was
lowest in this group (10 mg, p <0.05). In addition the time
interval to review was longest in those subsequently re-admitted
(median 5 weeks, p — 0.055). Oral corticosteroids were given to
most in hospital and peak flow rates monitored in the majority
(65%).
More of this group reported sleep disturbance and morning chest
tightness at interview, confirming the prognostic importance of
such continuing symptoms.
The failure to maintain oral corticosteroids or give inhaled
steroids or review such patients are shown to be the major




In the course of the survey, 17 patients had more than a single
admission with acute asthma to the hospital; 16 patients had two
admissions and a single patient three admissions. Frequent
hospital admissions for asthma may occur because of severe
disease, or sudden onset of severe wheeze, because of poor
compliance or undertreatment or may be related to other factors
such as patients' understanding of their disease and ability to
cope. To examine these interactions, some aspects of the
history and management of this group have been compared with
those having a single hospital admission.
METHOD AND PATIENTS
Of 139 patients involved in the entire survey full details
including admitting ward and details of hospital management were
available for 134. Of the five remaining patients, the case
notes were unobtainable for three, and for two others the
admitting ward was unknown. These 134 could be divided into
three groups:-
Group A - 61 patients with a single admission to medical wards
with no respiratory interest.
Group B - 56 patients with a single admission to medical wards
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Group C - 17 patients admitted more than once. Only the first
of these patients' admissions will be considered here.
History and management variables for these three groups were
compared by Chi squared testing for grouped data or
Kruskal-Wallis test, for medians and ranges. Averages were
compared by Student's t-testing. It was felt to be
unsatisfactory to simply compare the 17 re-admitted patients with
all those having a single admission, since this latter group has
been shown (Chapter 4) to contain groups of patients whose
management had been substantially different.
RESULTS
These are presented in tabular form in the ensuing pages, with
the relevant discussion adjacent.
The average ages of these three groups of patients were similar
(Table 26) and there were no differences in pulse rate on
admission, which is the best guide available to severity of the
index attack.
Likewise there were no differences in the median number of
previous hospital admissions or GP visits within the previous
year with exacerbations of wheeze. The time spent in hospital
was similar and all groups were recorded as having had
deteriorating asthma for similar lengths of time. The
proportions with a secure diagnosis of asthma (categories (i),
(ii) and (iii), Chapter 3, Table 11) were similar.
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TABLE 27
TREATMENT BEFORE ADMISSION. AND ON DISCHARGE FROM HOSPITAL
A B | C |
Single Single 1 First of 1
admission to admission to 1 more than 1
non specialist 1 one 1
specialist wards i admission 1
wards
|Before admission:
|No. (%) on inhaled CS 32 (52) 27 (48) | 10 (58) |
|No. on regular oral CS 4 1 I 0 j
1 After discharge:
|No. (%) whose Rx
| unchanged 23 (38) 16 (29) | 5 (29) i
|No. (%) on inhaled CS
40 (66) 47 (84) | 9 (53)* |
|No. whose dose of inhaled
j CS increased compared
| with admission
| (included those started
| on inhaled CS) (% of
| those discharged on
| inhaled CS) 17 (42) 33 (70) [ 2 (22)+ |
|No. (%) on oral CS at
| interview 24 (39) 28 (50) | 9 (53) (
|Median dose prednisolone
1 (nig) 16.5 20 j 10 # |
* p <0.025
+ p <0.005
# p <0.05 KW test
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There was therefore no evidence of any difference up to the time
of hospital admission between these three groups.
Similar proportions of each group were taking inhaled
corticosteroids before admission and only small numbers were on
regular oral steroids (Table 27).
Whilst by the time of discharge from hospital many more patients
in each group were taking oral steroids, at least in the short
term, the median dose of prednisolone on discharge was lowest in
the group of those subsequently re-admitted.
In addition fewer of this group (C) had inhaled corticosteroids




TREATMENT AND SUPERVISION IN HOSPITAL





























(77)* 30 (54) j 9 (53)
Aminophylline 1 16 (26) 17 (30) ! 8 (47)
Oxygen S 40
1
(66) 29 (52) I 12 (71)
* p <0.005
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The significant differences in various aspects of hospital
management (Table 28) are not surprising since they re-iterate
the findings in Chapter 4. The important fact to emerge from
this analysis is that in bald terms of treatment given, Group C
fared reasonably well. Thus most were given oral
corticosteroids in hospital (although no data on doses is
available) and a majority had peak flow rates monitored. In
general terms they were more intensively managed than Group A.
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TABLE 29
REVIEW ARRANGEMENTS AND SYMPTOMS AT INTERVIEW
1 A B | C
| Single Single i First of
|admission to admission to 1 more than
i non specialist 1 one






(48) + 51 (91) j 10 (59)
Median time to review
1
1
(weeks) 1 4 5*



















(51) 21 (37) | 12 (71)#





(61)# 20 (36) i 8 (47)
+ p «0.005
* p = 0.055 KW
# p <0.05
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Again more of Group C had review arrangements than Group A, but
still far fewer than Group B, and the median time to review was
longest in this group (Table 29).
Similar proportions of each group had a coherent plan in the
event of a further severe attack of wheeze (i.e. they would call
their own GP, go straight to hospital or vary this depending on
the severity of wheeze).
By the time of follow-up interview, more of Group C patients
reported sleep disturbance (although this did not reach
statistical significance with p = 0.01) and morning chest
tightness, compared with Groups A and B. The association of
such symptom reporting with the greater likelihood of subsequent
hospital admission confirms the importance of such symptoms as
those typical of poorly controlled asthma.
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GENERAL DISCUSSION
The important differences which this analysis show relate to
treatment and management arrangements at the time of hospital
discharge. Others have commented on the risk of death from
asthma in the period soon after discharge from hospital
(Macdonald, 1976(b); Ormerod, 1980). The association of
continuing symptoms of poorly controlled asthma is shown here to
be associated with the lesser use of oral and inhaled
corticosteroids and greater likelihood of further admission.
A protective role for inhaled corticosteroids was also shown in
Chapter 4, since a significantly greater proportion of patients
from medical wards with a specialist respiratory interest were
discharged on this form of therapy and fewer of these were
re-admitted.
This analysis also confirms the importance of early review of the
asthmatic patient, so that the recurrence of symptoms, whether
due to withdrawal of oral corticosteroids, or nebulised
bronchodilators or to return to the home environment, may be
appreciated at an earlier stage.
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CHAPTER 7 - A SURVEY OF ASTHMA MANAGEMENT IN THE COMMUNITY
SUMMARY
General practitioners of five health centres serving a population
of 120,000 (17% of Glasgow's population) completed a simple
encounter form for 782 attendances due to asthma during a two
month period. This sample was estimated to represent 56% of all
such consultations over this period. Eighty one consultations
were recorded by a single practitioner with a special interest in
asthma, 701 by others. The practitioner with a special interest
in asthma saw cases more frequently (p<0.005) and judged more to
be adequately controlled (p<0.05) than others. More of his
cases were receiving inhaled corticosteroids (p<0.005) and fewer
long term oral corticosteroids (p<0.05).
If a change in therapy was made, this practitioner increased
inhaled therapy most often (68%) , with a course of oral
corticosteroids his second option (18%) . Other practitioners
were most likely to use antibiotics (56%) and least likely to use
oral corticosteroids (15%) in these circumstances. This sample
of general practice asthma consultations shows the same
discrepancies in asthma management as were observed in the
hospital survey where differences in management between
physicians with an interest in asthma and others were in addition




Several studies of childhood respiratory complaints, either
performed as part of the school medical service (Anderson, 1981;
Lee, 1983; Speight, 1983) or confined to a single practice
(Levy, 1984) have shown that asthma is underdiagnosed and
specific therapy often not used.
Similar surveys of adult asthma management are more difficult to
organise, depending on maximum co-operation of practitioners, the
use of disease registers and research personnel (Modell, 1983).
Anecdotal accounts, extrapolating from retrospective surveys of
deaths from asthma (Seaton, 1978) suggest that adult asthma
management is often suboptimal, but the evidence for this is
lacking.
A survey of the management of asthma in a total population of
120,000 was, therefore, performed as the first stage of an
evaluation of an education programme which is described in
Chapter 8.
METHOD
The practitioners of five large health centres, two suburban and
three serving inner city areas took part in the survey. The
study population of 120,000 represents 17% of the Glasgow
population (720,000).
Information on asthma attendances at these practices was recorded
in September and October 1985. No diagnostic criteria were
imposed upon participating practitioners for the purposes of the
s tudy.
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Practitioners were asked to complete a simple encounter form
every time they saw a patient whom they considered to have
asthma. The information required was set out as a series of
defined options, so that forms could be completed by ticking the
appropriate boxes (see Appendix 2) . As well as the age and sex
of the patient, the following information was sought:-
(i) The interval since the patient last attended because of
asthma - this allowed for the possibility of a new diagnosis of
asthma being made.
(ii) The reason for attendance: Four options were given, namely
(1) routine visit, adequate control, (2) routine visit,
inadequate control, (3) exacerbation, non urgent consultation and
(4) exacerbation, urgent consultation. Detailed notes on these
four categories were contained on the inside front cover of the
pad of forms, so that they were visible each time a form was
completed.
(iii) Current steroid therapy: Three categories, not mutually
exclusive were given. These were inhaled, intermittent oral and
regular oral.
(iv) Further management: Four options were given; (1) continue
as before, (2) change regime, (3) refer to outpatients, (4) refer
for admission. If option (2) was chosen there were six
categories to describe the changes made. These were to decrease
or increase inhaled therapy (this option including start inhaled

























RAW DATA IN TABLE30, APPENDED
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bronchodilator or injection (not further specified).
Each participating practitioner and associated trainees were
given a pad of encounter forms and the opportunity to clarify any
queries. Completed forms were collected weekly.
The survey population included a single practitioner (X) with an
avowed special interest in asthma, who ran a weekly asthma
clinic, used peak flow recordings regularly both in the surgery
and at home, and functioned in a similar manner to a specialist
asthma clinic. This practitioner's practice was, therefore,
also surveyed and his results akin to an internal standard of
community asthma care compared with others. Differences between
groups were compared by Chi squared analysis.
RESULTS
Seven hundred and one attendances for asthma were recorded by all
other practitioners and 81 by X over the two month period.
The average age and proportions of different age groups
(Table 30) was similar for these two groups of cases. Cases
seen by X were reviewed more frequently (p<0.005) and were less
likely to be judged poorly controlled when seen (p<0.05)
(Figure 6). The smaller proportion of emergency consultations
by X may not be a significant finding since such calls occurring
in the health centre from which he practises would be dealt with
on a rotating basis by himself and colleagues.
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RAW DATA IN TABLES 31 AND 33, APPENDED
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More of X's cases were receiving regular inhaled corticosteroids
(p<0.005) and fewer long term oral steroids (p<0.05) (Table 31)
(Figure 7). Table 32 shows the outcome of all consultations,
the somewhat greater proportion of cases having therapy altered
by the group of all other practitioners being related in all
probability to the greater proportion of this group judged poorly
controlled.
Specific management changes (Table 33 and Figure 7) show that
cases seen by all other practitioners were most likely to be
treated with antibiotics, if any change was made. Similar
proportions of cases were treated with an increase in inhaled
therapy (not further specified) or oral bronchodilator.
Practitioner X, however, used antibiotics and oral
bronchodilators significantly less often, relying on increased
inhaled therapy to a far greater extent. Oral corticosteroids
were used equally by both groups.
DISCUSSION
This survey documents current asthma management in a large number
of general practice consultations. By using a large survey
population to obtain such a sample of transactions in asthma care
it was believed that individual variations in practice would be
lost and the broad outline of current practice seen.
The fact that no diagnostic criteria were imposed for the
purposes of the study may have contributed to the large number of
transactions recorded. No attempt was made to define the
management of other patients attending with asthma - like
symptoms but with other diagnoses. Such a subgroup,
particularly in middle aged adult males has been shown in a total
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community survey in Tucson, Arizona (Dodge, 1980 and 1986).
However, since at least in childhood asthma, naming the condition
as such has been shown to be a major determinant of using
specific therapy (Speight, 1983) it seems likely that such
patients (with asthma-like symptoms but not so diagnosed) will
not have had specific asthma therapy exhibited to any greater
extent than the sample described here.
The survey shows marked differences in management between a group
of around 100 practitioners and a single one with a special
interest in asthma.
An over-emphasis on the use of antibiotics is confirmed
(Marks, 1983), a form of therapy which has no influence on the
duration or outcome of an exacerbation of asthma (Graham, 1982).
Since such therapy was the only treatment given to 64 of those
treated by all other practitioners (17% of those whose therapy
was changed, and 30% of all those treated with antibiotics) a
deal of unnecessary morbidity must inevitably have followed. No
patient treated by X with antibiotics received only this form of
therapy.
Oral corticosteroids were used with equal frequency in both
groups of cases. However, where in X's practice corticosteroids
were second line therapy, after an increase in inhaled treatment,
other practitioners used corticosteroids as their fourth and
least likely treatment option (after antibiotics, oral
bronchodilators or inhaled therapy).
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Twice as many cases seen by X were receiving inhaled
corticosteroids. Since X regularly monitored peak flow rates
and had many patients using diary cards to record symptoms at
home it is probable that in most of these cases the need for and
response to inhaled corticosteroids will have been documented.
In a descriptive study, however, it is impossible to draw a
causal relationship between steroid usage and the observation
that more of X's cases were considered well controlled. This
latter observation probably has at least as much to do with X's
pattern of clinical practice.
The two groups of cases compared in this chapter were not
controlled or known to be similar in terms of severity of asthma,
but if any difference existed it seems more likely that the
practitioner with a special interest in asthma will have
accumulated more of the severe or chronic asthmatics than the
opposite bias. Bearing this in mind, this survey of community
asthma management shows many of the features described in the
previous hospital studies (Chapters 3 and 4). In both settings
those with a special interest in asthma are seen to use inhaled
corticosteroids more often, and to manage poorly controlled

























aged < 4 years 46 (7) 6 (7) 1
aged 5-15 years 99 (14) 9 (11) 1 ns |
aged > 15 years 534 (76) 66 (82) 1
where age not stated 22 (3) 0 1







with new diagnosis of 1
asthma 61 (9) 2 (2) 1)
seen within 1 month 299 (43) 62 (77) 1)
seen 1-6 months 1 )«0.005 1
previously 153 (22) 15 (18) 1)
> 6 months previously 180 (25) 1 (1) 1)








(1), no. (%) 267 (38) 43 (53) 1)
Poorly controlled (2, 3 1) <0.05
or 4), no. (%) 411 (59) 37 (46) 1)
Emergency (4 only), 1)
no. (%) 101 (14) 3 (4) 1
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SPECIFIC CHANGES IN THERAPY
Cases seen |
by all other |
practitioners|
Cases seen 1
by X 1 p !
|No. having therapy
| altered 375 1 34 |
|No. (%) having inhaled
| drugs started or
| increased 147 (39) | 23 (68) | <0.005 |
|No. (%) given oral
| corticosteroids 55 (15) | 6 (18) [ ns |
|No. (%) given antibiotics 210 (56) 6 (17) | <0.005 |
|No. (%) given oral
| bronchodilator 138 (37) i 5 (15) S <0.01 |
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CHAPTER 8 - ASSESSMENT OF AN ASTHMA MANAGEMENT PROGRAMME FOR
GENERAL PRACTICE
SUMMARY
A survey of current general practice asthma management was
performed before and after implementation of an Asthma Management
Programme. The survey was carried out by recording details of
asthma attendances to practitioners in five Glasgow Health
Centres for the same two month period in two consecutive years.
Repeat prescriptions for steroid inhalers and DSCG were also
monitored. In the intervening period, practitioners in two of
the five health centres (the Active Group) had access to a
prepared programme of information on asthma management, health
education material for their patients and peak flow meters
presented at an open meeting with two local chest physicians.
There was an increase in the use of inhaled steroids in the
Active Group only, as judged by practitioners' opinions as to
how, if at all, their practice had changed, and confirmed
independently by monitoring repeat prescriptions. This group's
use of antibiotics in the management of asthma decreased and
there was an upward trend in the use of oral corticosteroids.
No such changes were seen in the control group. This locally
evolved programme of practitioner information and patient
education material is, therefore, judged to be a moderate success
and further use of it worthwhile.
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INTRODUCTION
Following the survey of current asthma management practice in the
community described in Chapter 7, a programme of educational
material and discussion for general practitioners and their
patients which had been prepared was introduced to half of the
survey population.
To assess whether this programme had had any measurable impact,
its effect was monitored in four ways:-
1 By repeating the survey of asthma attendances.
2 By recording hospital attendances by patients of these
practitioners.
3 By monitoring repeat prescriptions of specific asthma drugs.
4 By questioning practitioners themselves.
The full development and implementation of this programme and its
evaluation are now described.
METHOD
1 Patients
The general practitioners of five large health centres, two
suburban and three serving inner city areas, with a patient
population of 120,000, took part in the study. These health
centres were chosen because they send patients to two
participating general hospitals and because they could be
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FIGURE 8: STUDY DESIGN
| SURVEY POP. 120,000 SERVED BY APPROX. |




















































+ W.T.E. = whole time equivalent.
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i
subdivided into two groups (one suburban plus one inner city, one
suburban plus two inner city), equal in size. In addition these
two subgroups refer patients to both of the participating general
hospitals approximately equally, so that any change in one
hospital's practice would not unduly bias the findings.
2 Study Design
This is shown in Figure 8. Information of the following three
categories was recorded from all participating practices for two
months in two consecutive years. In the interim half of the
survey population (the Active Group) were introduced to the
prepared asthma programme (see below).
The three categories of information were:-
(i) General practitioner attendances - the information described
in Chapter 7 (Methods) was collected for attendances to general
practitioners for asthma in September and October 1985 and 1986.
(ii) Hospital attendances of patients from these practices to the
two local general hospitals and the city's children's hospital
were monitored for six months (June - November 1985 and 1986).
Casualty attendances and hospital admissions were recorded
separately.
(iii) Repeat prescriptions for steroid inhalers (Becotide,
Pulmicort, Becloforte, Bextasol, Ventide) and sodium cromoglycate
(Intal) were monitored by clerical staff in two health centres,
one each in the active and control groups in September and
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October 1985 and 1986.
Finally, after each period of recording of consultations
practitioners were asked to estimate the proportions of asthma
cases in which they had been able to complete an encounter form.
This was done by providing a visual analogue scale in the form
0 20 40 60 80 100%
After the second survey period, in November 1986, practitioners
in the Active Group were sent a questionnaire designed to
evaluate the various parts of the Asthma Programme. They were
invited to assess the four elements of the programme on a scale
of 0 - 3 (0 = unhelpful, 1 = not particularly helpful, 2 = of
some value, 3 = very helpful). Further questions designed to
determine any change in practice which the survey and Asthma
Programme may have produced were also included.
3 The Asthma Management Programme
A programme of educational material and aids for the general
practitioners of the Active Group health centres was prepared.
This had four main elements
1 Information Folder for practitioners.
2 Asthma Education Leaflet for patients and/or parents.
3 Peak flow meters.
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4 Meeting with local chest physicians.
The information folder (see Appendix 1) briefly described
categories of asthma, and how to arrive at the diagnosis of
asthma, based either on symptoms, simple measurements of peak
flow rates, or response to bronchodilator or corticosteroids.
Flow diagrams describing the local consensus opinion on the
management of asthma in infants, children, adults and in
emergencies were also provided.
An asthma education leaflet designed to increase patient's
awareness of the disease process in asthma, the aims of treatment
and signs of poorly controlled asthma was prepared with the
technical help of the local Health Board's Health Education
Department (see insert). As part of the development of this
leaflet, its reading ease score was calculated. The average
score for the text was 73, a reading ease level between that of
the Sunday Post and Glasgow Herald which an estimated 80% of
readers would understand.
Mini-wright peak flow meters were made available so that general
practitioners could use them as frequently as they wished, either
in the surgery or by asking patients to use them at home. These
resources were presented to the practitioners of the two health
centres at an open meeting given by two local chest physicians at
which there was wide ranging discussion of the problems of asthma
management in the community.
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4 Statistical Analysis
Differences between groups were examined by Chi square testing,
p<0.05 being taken as significant. Exact values for p are given
where appropriate in the text. Averages were compared by
Student's t-test.
A controlled evaluation of the effect of the management programme
was therefore planned. However, the presence of a single
practitioner with a special interest in asthma, whose management
differed significantly from others (see Chapter 7) in one of the
control group health centres was a confounding factor. For
reasons discussed more fully in the next section this individual
practitioner's results are not included in this part of the
analysis.
RESULTS
(i) General Practitioner Encounters
The data is presented to show the practice in control and active
groups in 1985 and 1986 in order that any secular trend be
clearly separated from a change due to any effect of the Asthma
Programme. As shown in Table 34, the practice of the
practitioner with a special interest in asthma (X) did not change
from 1985 to 1986. Since this practitioner's returns formed 26%
of the control group total in 1985 and a much larger proportion
(52%) in 1986, a discrepancy which falsely biases the control



















35 212 107 109
NS
25 87 46 71
21 93 42 54
p<0.005
11 35 15 67
New <1 1-6 >6 months New <1 1-6 >6 months
diagnosis diagnosis
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Table 35 shows the numbers of encounters due to asthma, the
average age and some other characteristics of those encounters.
Table 36 shows how many consultations resulted in changes in
management and details some of these.
The number of encounter forms returned from the active and
control group fell by about half from 1985 to 1986. There was
little change in the practitioners' estimates of the proportions
of actual cases seen in which a form was completed (see below)
between 1985 and 1986 suggesting a genuine difference in
consultation rate over these two months in 1985 and 1986. The
average rate of acute asthmatic episodes reported to the Royal
College of General Practitioners research unit in September and
October fell from 24.7 per 100,000 in 1985 to 19.1 per 100,000 in
1986, suggesting that at least some of the observed decline was
genuine.
Whereas in 1985 the proportions of cases seen at different time
intervals and considered to be well controlled was similar in the
active and control groups, by 1986, well after exposure to the
Asthma Programme more cases were being seen at shorter time
intervals (Figure 9 and Table 35) and more were considered well
controlled in the Active Group (Figure 10 overleaf and Table 35).
There was an upward trend in the use of inhaled steroids in both
active and control groups in 1986 compared with 1985 suggesting a
secular trend (Figure 11 and Table 35).
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FIGURE 10: PROPORTION OF CASES JUDGED TO HAVE WELL CONTROLLED
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In terms of therapeutic changes made (Table 36 and Figure 12)
there was a significantly greater proportion of cases in the
Active Group treated with antibiotics in 1985 which was
eliminated in 1986. This was associated with an upward trend,
not reaching statistical significance in the proportion of cases
treated with a course of oral corticosteroids.
2 Hospital Attendances
There was an overall decline in the number of children seen at
Accident and Emergency from 1985 - 1986, although no change in
either group in the number of cases admitted. In terms of adult
attendances, numbers in the study group increased somewhat
compared with the control group (Table 37).
3 Repeat Prescriptions
The numbers of prescriptions for steroid inhalers and Intal given
in September and October 1985 and 1986 in one health centre in
each of the active and control groups are shown (Table 38
overleaf). Over this period there was no change in the repeat
prescribing system in the health centre in the control group,
whilst in the active group health centre the introduction of a
computer-based system led to a 35% increase in all prescriptions
issued between 1985 and 1986. The observed increases in
prescriptions for steroid inhalers and Intal greatly exceeded
this general increase, the difference remaining highly
significant after taking this into account.
Although no figures for the total number of repeat prescriptions
issued during the two survey periods were available in the
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| inhalers 8 | 34* 13 1 1
1 1
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control group health centre these were monitored for the
subsequent seven months (November 1986 - May 1987). As shown in
Table 39 this showed a maximum variation in the total number of
repeat prescriptions written of 12%. As stated already, there
was no change in this health centre in the numbers of
prescriptions for asthma specific inhalers issued.
4 General Practitioners Views of the Survey and Asthma
Programme
The number of practitioners who returned estimates for the
proportion of cases for whom an encounter form had been completed
fell from 1985 to 1986. The estimated proportions, however,
remained constant (Table 40 overleaf).
Nineteen of the 36 practitioners in the Active Group (53%)
returned the questionnaire designed to evaluate their opinions of
the elements of the Asthma Programme.
The average rating for the meeting with local chest physicians
was 2.7, for the information folder 2.3, the patient education
leaflet 2.2 and the readily available peak flow meters 2.5.
Most felt that exposure to the programme had altered their
management of asthma to some extent (5/19 "a lot",
13/19 "a little", 1/19 "not at all").
Specific questioning about four categories of asthma drugs
revealed that this had resulted in an increase in the use of
inhaled steroids, with no perceived change in use of inhaled
sympathomimetics, oral steroids or theophyllines.
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TABLE 40
PRACTITIONERS' ESTIMATES OF PROPORTIONS OF ASTHMA CASES SEEN IN
WHICH AN ENCOUNTER FORM WAS COMPLETED
1 1
1 1
1985 1 1986 1
1 1
1 1
|No. (%) of practitioners |





I 48 (48) |
1 1
1 1
|Average estimate of proportion |

















This investigation represents an attempt to measure the effect of
a defined programme aimed at improving asthma care in a large
population. It is important to differentiate the attempt at
measuring the effect from any perhaps longer term change the
programme may have had that could not be measured. Other
projects of a similar nature may have experienced this same
difficulty (Modell, 1983; Hilton, 1986a). Surveying such a
large population restricts the investigator to event recording -
general practitioner attendances, repeat prescriptions, hospital
visits. These describe some episodes in the life of an
asthmatic but do not monitor his every day level of asthma
control. This is obviously more important but probably
impossible to measure on such a large scale.
Thus an asthmatic may tolerate symptoms of troublesome asthma for
a long time, attend his practitioner with uncontrolled asthma, be
started on an inhaled steroid and have a much improved quality of
life, whilst still suffering a further exacerbation one year
later. This would not necessarily be recorded as any
improvement by the indices measured, unless he were receiving a
repeat prescription, although it would represent a real
improvement for that individual.
Some positive pointers of improved outcome are observed, even
given these insensitive measuring tools. Practitioners
themselves felt that their management of asthma had altered and
independently identified an increased use of inhaled steroids as
the major part of this. This reflects a similar emphasis in the
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information folder.
Although this was not reflected by any change in the proportion
of cases receiving inhaled steroids over the two month periods
during which practitioner attendances were monitored there was a
substantial increase in the repeat prescribing of inhaled
corticosteroids only in the active group health centre. The
static proportion of attending patients receiving inhaled
corticosteroids could reflect the pattern of patient initiated
consultations in general practice with patients tending mainly to
see their doctors when unwell. The figures obtained do not deny
the possibility of an increased proportion of stable asthmatics
not seen within that two month period, who in fact may only have
registered in the repeat prescription figures.
The increase in repeat prescriptions of steroid inhalers and
DSCG, and practitioners' independent assessment that their use of
inhaled steroids had increased was associated with the lesser use
of antibiotics and an upward trend in the use of oral
corticosteroids in the management of unstable asthma. This
suggests a change in thinking about the underlying pathological
process away from bacterial infection which is a positive trend
(Marks, 1983; Levy, 1984; Seaton, 1978).
Others have commented on the importance of obtaining information
on all events when an audit of any kind is made (Sheldon, 1982) .
This is self evident. It has been suggested that systems which
bypass the doctor's participation, although not his co-operation,
are preferable and that data from committed clerical staff is of
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higher calibre. By this token the data on repeat prescribing
should be most reliable, and it is, therefore, noteworthy that a
significant change in practice was observed here. There is no
reason to believe that omissions in the practitioners' returns
occurred on any but a random basis, with perhaps a tendency for
emergency house calls to be under-represented.
The proportion of cases in which a new diagnosis of asthma was
made in the course of the survey was consistently higher in both
active and control groups at around 10% than in X's practice (2%)
(Table 34). This may represent a longer term benefit of the
survey both in the active and control groups due to a general
raising of consciousness of asthma as an entity. This
phenomenon was also observed by Modell (1983); in that study
92 asthmatics were followed up with interviews a year apart.
These represented 63% of all asthmatics identified from their
practice disease register. In addition, however, in the course
of that study a further 66 new asthmatics were identified. As
already mentioned, in children at least it has been shown that
naming the condition as asthma is a major determinant of giving
appropriate treatment (Anderson, 1981; Speight, 1983).
The slight increase in casualty attendances by patients of the
active group health centre may reflect an increased awareness of
the significance of their symptoms. The lack of change in the
number of hospital admissions with acute asthma suggests that the
programme had not sufficiently altered the general level of
asthma control in the test population. However acute
deterioration in asthma can have many causes, only some of which
may be preventable.
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The programme consisted of four main elements, as described.
From practitioners' comments and by observing the use made of
peak flow meters and patient education leaflets it was apparent
that these two elements were less frequently used than
anticipated. Thus although many workers have commented on the
usefulness of the peak flow meter as a tool (Seaton, 1978;
Cushley, 1983) one can only presume that the programme failed to
persuade practitioners of this in everyday practice, either as a
tool for themselves or for their patients to use at home. In
addition relatively few patients received copies of the patient
education leaflet, although the feedback from those who had
received it was favourable.
In summary, therefore, an attempt was made to improve
communication between doctors and between doctors and patients
about asthma and its treatment, by means of a locally agreed
programme. Its implementation was monitored and several
positive trends observed, particularly in terms of an increased
use of inhaled corticosteroids. The high proportion of reported
cases in which a new diagnosis of asthma was made suggests a long
term benefit of the study which was not further evaluated.
Practitioners value discussion and consultation with local
hospital specialists and dissemination of information by this




CONSULTATIONS BY THE PRACTITIONER WITH A SPECIAL INTEREST IN
ASTHMA, 1985 AND 1986
1985 1986
i n | 81 140
|Average age (years + ISD)| 45.8 ± 23.2 45.5 ± 21.3
|Interval Since Last Seen |
|New diagnosis, no. (%) j 2 (2) 4 (3) )
|< 1 month no. (%) 62 (77) 95 (68) ) ns
|> 1 month no. (%) | 16 (20) 40 (29) )
|Not stated no. (%) 1 1
|Reasons for Attendance i
|(See Text) 1
|Routine, good control j )
| (1), no. (%) j 43 (53) 78 (56) )
|Poorly controlled (2,3 | ) ns j
| or 4), no. (%) | 37 (46) 60 (43) )
|Not stated, no. (%) | 1 2 )
|Current inhaled steroid, |
| no. (%) j 42 (58) 74 (62) ns |
|Current regular oral j
| steroid, no. (%) j 1 (1) 2 (1)
|Changes in Management j
|None, no. (%) j 45 (56) 77 (55) )
|Change therapy, no. (%) | 34 (42) 58 (41) ) ns |
|Refer to OPD, no. (%) | 0 (0) 2 (1) )
|Refer for admission, |
| no. (%) | 2 (1) 1 (1)
|Specific Therapeutic i
|Changes (as % of those '
|whose theraov was 1
|changed) j
|No. (%) |
| Increase inhaled Rx | 23 (68) 38 (66)
| Course of oral |
| corticosteroids | 6 (18) 15 (26)
| Course of antibiotics | 6 (18) 8 (14)
| Oral bronchodilator | 5 (15) 6 (10)
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TABLE 35
PATIENT AND CONSULTATION CHARACTERSITCS
1985 1 1986
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1 21 (9) | 11 (8) j
|< 1 month 212 (45) 1 87 (38) | 93 (42) | 35 (28) |
11- 6 months 107 (23) | 46 (20) 1 ^2 (19) | 15 (12) |
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| control (1) 178 (38) | 89 (38) | 92 (41) | 41 (32)*|
|Poorly controlled 1 1 1
I (2, 3 or 4) 278 (59) 1133 (58) 1127 (57) | 81 (63) |
|Emergency (4 only) 73 (15) 1 12 (12) | 30 (13) | 23 (18) |








ITheraDV (%) 1 1 1
| None 264 (56) 1136 (59) 1124 (56) | 64 (50) |
|Inhaled 140 (30) 1 59 (26) | 66 (34) | 51 (40) |
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| No change in 1 1 1 1
| treatment 202 (43) I 96 (42) 1100 (45) 1 45 (35) |
| Change in treatment 249 (53) |126 (53) 1112 (50) I 82 (63)+|
| Refer to 1 1 1 1
| outpatients 10 (2) 1 6 (3) 1 7 (3) I 0 (0) |
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| Increase inhaled Rx 106 (43) 1 41 (32) | 49 (44) 137 (45) |
| Oral 1 1 1 1
| corticosteroids 38 (15) 1 17 (13) I 21 (19) I 10 (12) |
| Antibiotics 153 (61) | 57 (45)* I 53 (47) I 38 (46) |










HOSPITAL ATTENDANCES FOR ASTHMA
1985 1 1986 1
Active | Control | Active 1 Control |













































































CHAPTER 9 - CONCLUSIONS
These studies were initiated in an environment, more fully
outlined in Chapter 1, where asthma mortality rates in the U.K.,
and elsewhere, had remained unaltered over the thirty years which
had seen the introduction of oral and inhaled corticosteroids and
inhaled beta agonists. Surveys of deaths from asthma had shown
that preventable factors could often be shown in retrospect to
have contributed to death with under-treatment, under-supervision
and often poor understanding of the nature of the disease.
Surveys of childhood asthma had shown under-diagnosis and
under-treatment to be common, and a cause of preventable
morbidity, but large cohort of adult asthmatics had not been
assessed in a similar manner.
The pilot retrospective survey (Chapter 2) suggested that
under-treatment and under-supervision was occurring in a
significant proportion of adult asthmatic hospital admissions, a
finding recently corroborated by Osman (1987). This pilot study
also helped define the aims and methods of the prospective audit
(Chapters 3-6). It was felt important that this audit should be
non-interventionist, not least because this allowed the full
approval of all medical units in the hospital. This limited the
measures of outcome which could be made to some extent. In the
final analysis, however, a critical assessment of current
symptoms may well be at least as useful as a single peak flow
recording or set of pulmonary function tests (often performed
under variable, or unknown bronchodilator cover).
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The crucial step of case-finding was performed by daily contact
with medical and nursing staff responsible for emergencies over
the previous 24 hours. In this way a cohort of patients was
identified prospectively and then characterised in terms of
previous asthma severity and treatment, hospital management,
understanding of disease and treatment and outcome. Such a
cohort has not previously been described. The 81% follow-up
rate allows the conclusions drawn to be applied more widely.
The observation that many patients (at least 34%) had continuing
symptoms of poor asthma control confirms other evidence that the
period immediately after hospital discharge with asthma is an
unstable one: several studies of deaths from asthma have
commented on the 10-20% who die shortly after discharge from
hospital (MacDonald, 1976b; Ormerod, 1980). It raised the
possibility that under-treatment and under-supervision was
occurring and led to the comparative studies outlined in
Chapters 4-6. These showed that general medical units with one
respiratory physician attached and middle grade "respiratory"
staff made a specific diagnosis of asthma, used inhaled and oral
corticosteroids and monitored response to therapy by peak flow
recordings more often and supervised patients more closely after
discharge, than did general medical units with other specialist
bias. That the management of such units differed was not of
itself surprising, but that this should be so sharply related to
outcome in two comparable groups of patients is an indication for
properly used modern, asthma therapy. It shows that preventable
morbidity is occurring on a regular basis. Even amongst those
admitted to medical units with a specialist respiratory interest
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23% reported regular sleep disturbance due to wheeze since
hospital discharge. Until it is proven that such a proportion
of cases cannot be further improved, these figures do not allow
complacency even on the part of such units.
The findings that the major differences between those
subsequently re-admitted compared with others lay in the
under-use of oral and inhaled corticosteroids after discharge
from hospital, and in a longer time interval to planned review
emphasis the importance of close supervision of this unstable
period when the risk of death from asthma may be greater.
Comparison of previous history and of management and outcome
variables between those labelled asthma and COAD showed that
older males with no objective pulmonary function data recorded
were more likely than others to acquire the latter less precise
diagnostic label. Although such a diagnosis was not associated
with differences in the use of oral or inhaled corticosteroids
compared with those labelled asthmatic, it was associated with
the lesser use of peak flow recordings to monitor progress -
perhaps perpetuating the problem. The possible under-diagnosis
of asthma in older males reporting symptoms of variable wheeze
(similar to those reported by females with asthma) was also
reported in the long term follow-up study of respiratory
morbidity underway in Tucson, Arizona (Dodge, 1986).
The conclusions of the community survey of asthma management
(Chapter 7), which was also entirely non interventionist but
accumulated data on a large number of consultations, show a
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FIGURE 13 (from Charlton, 1986)
500 1
O
10 i 1 1 1 1 i
1951 1955 1960 1965 1970 1975 1980
Year
Comparison between trends in aggregate of avoidable causes
of death* and all other causes (ages 5-64).
*lncludes tuberculosis, cervical cancer, chronic rheumatic
heart disease, hypertension, stroke, appendicitis and
cholelithiasis and cholecystitis.
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noticeable congruity with the hospital-based data. In both
hospital and general practice those with an interest in asthma
and, therefore, presumably more aware of current specialist
practice were found to use oral corticosteroids for exacerbations
of asthma and long term inhaled corticosteroids more frequently
and to review patients more often. These similarities raise the
possibility that interested physicians perceive the long term
nature of adult asthma and the need for a long term view.
Asthma has been identified (Rutstein, 1976) as a condition which
is amenable to treatment and by corollary as a suitable marker of
quality of delivery of health care. In many developed countries
morbidity from other such marker conditions (including
tuberculosis, cervical cancer, chronic rheumatic heart disease,
hypertensive disease, stroke, appendicitis and cholelithiasis)
has declined dramatically over the thirty years to 1980
(Figure 13) (Charlton, 1986).
The recent observations that the prevalence of asthma may in fact
be increasing (Fleming, 1987) could partially explain why asthma
mortality has not declined. The work described in this thesis
provides other evidence as to why mortality has not altered.
Finally, in Chapter 8 evidence is presented that by local
discussion and dissemination of information doctors' management
of asthma can be changed. The increase in repeat prescribing of
inhaled steroids and cromoglycate is taken as a positive outcome.
This survey was population-based (comparing two groups of
approximately fifty practitioners and 60,000 patients). It was
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not possible to incorporate any measurement of symptomatic
improvement in this survey. However, the benefit of inhaled
corticosteroids over bronchodilators and other more symptomatic
treatment has recently been studied prospectively over a
prolonged period (Horn, 1988).
The re-education of the medical profession about asthma first
suggested in 1978 by Seaton and re-iterated by Osman (1987)
remains a priority. The data presented here provides a firm
body of prospectively gathered objective data to underpin that
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ASTHMA AUDIT - DISCHARGE SUMMARY & CASE RECORD INFORMATION
NAME: WrdlSL^ HOSP. NO.
ADDRESS: f^ (Pd\S—
DATE OF BIRTH:^yJjTs?
T.F.NGTH OF HOSPTTAI. STAY (DAYS') . %LEN I L ( )
_____
DELAY - DISCHARGE SUMMARY (DAYS)
SEEN BY GP OR DDS BEFORE ADMISSION: GP ^Dtf§) •/ NO
TREATMENT BEFORE ADMISSION: i.v. steroids
i .v ./i .m. Theophylline
SC Terbutaline ar equivalent
None
REASON FOR DETERIORATION f^0^'
| ^ <r s><o
DURATION POOR ASTHMA CONTROL 5 1 M w ■
INITIAL PULSE RATE (0-200) \ I O k>. 'toi
INITIAL PEFR (0-500) 0 = not recorded Q
10 = unrecordable
LUNG FUNCTION MONITORED: PFTs / PEFR /(jtfj).
SKIN TESTS POS / NEG / NOT KNOWN
ARTERIAL GASES CHECKED NO / p02 >60 / p09 <60 i^ 0
STEROIDS: Oral / iv bolus / oral + iv / iv infusion / nil
AMINOPHYLLINE: bolus / infusion / nil
0_ -,„//> NONE / 24% / 28% / 35, 40% / >40%2 \/<2^U^hA -e Iff*
CHANGE IN TREATMENT ON DISCHARGE: Incfeggg^^gi RxIncFeaseiffnaled Rx
Decrease' inhaled Rx
C*T lA- 7~SD Decrease oral Rx
No change
SPECIFY:
INHALER TECHNIQUE CHECKED: YES /(No)
HOME ON STEROIDS: (^YE?)/ NO DOSE: -2o
FOR HOW LONG: DAYS (0-30) <f(U
TILL SEEN GP/CLINIC jOt~P S^~Y
LONG TERM .
CLINIC REVIEW INTENDED: RESP^/ MED / NO
WEEKS:
^Ar;
ASTHMA AUDIT - RECENT INPATIENT QUESTIONNAIRE
DATE SEEN: JL ' SURVEY NUMBER
NAME: UNIT NO
ADDRESS: . pRI NO
DOB: ^ / ]VS3-
SEX: MALE / FEMALE
1 SMOKER: (JT)/ Y / EX Code: 0/1/2
2 DATE OF DISCHARGE: Q"/ _U / ,
3 LENGTH HOSPITAL STAY (DAYS) g
JOB HISTORY y. Q\ (QhA
/ff 1 2 3
4 OCCUPATIONAL ASTHMA: /Noj/Poss / Prob / Definite
5 HOW LONG HAVE YOU HAD ASTHMA? X(i^.
Childhood [98]/ late onset (years)/New diagnosis [99]
6 PREVIOUS HOSPITAL ADMISSIONS (Number) <£>
7 EXACERBATIONS IN PAST YEAR - GP ATTENDANCE: (Number) jg? • / •
8 HISTORY OF SUDDEN SEVERE ATTACK: (NCT/ YES
9 PREVIOUS PFTs: (mj/ YES / GRI
10 REGULAR FOLDCW-UP BY GP: * YES
11 REGULAR HOSPITAL CLINIC ATTENDANCE FOR ASTHMA: (NO)/ YES
12 TREATMENT BEFORE ADMISSION: IU R . W|
^ UoJtvfc-|
13 PROPHYLACTIC Rx BEFORE ADMISSION: (NO>[0] ' ]




14 HOW REGULARLY TAKEN (Estimate days/week full dose taken) ^ s.
15 ARRANGEMENT TO START STEROIDS IN EVENT EXACERBATION: (j#\)
16 If so, Starting Dose PN (0 - 50 mg)
17 HOW LONG HAD CHEST BEEN GETTING WORSE BEFORE ADMISSION (days),
18 HAD YOU ATTENDED GP: (^3)/ YES






2C SEEN BY GP OR (PES^EFQRE ADMISSION: NO /(YEp-/ PHONED IN
No=0;~Seen by GP=1 Phoned in by GP=3
" DDS=2 " " DDS=4
21 TREATMENT THEN: /NiT?[0] "
,[1] (Su&rfTablets [2]
NCT> PEFR / PFTs
1 2
NO / Can't remember /(YES%
0 1
22 TESTS IN HOSPITAL:
23 BLOOD GASES CHECKED
24 Do you remember this being painful? NO /^YES?/ Not applic.
0 1 9
25 INHALER TECHNIQUE CHECKED: NO /(Dr). / Nurse / Can't remember
0 2 .3
26 EXPLANATION OF DRUG ACTION
27 STEROIDS GIVEN (Tabs)
: (p)/ yYES / Can't remember2
NO/(yesV Can't remember
0 2
28 DOSE AT TIME OF DISCHARGE: 0-50mg / Don't know / Not applicable
98 99
29 HOW LONG BEFORE STEROIDS TO BE STOPPED: 0-30 days tOd^.
99 = no instructions
98 = longterm Rx
30 ANY CHANGE IN REGULAR TREATMENT? NO / YES (NO = 0; YES = 1)
1 Theophylline
CT.2 Inhaled B2 agonist?
i 3 Inhaled Atrovent /
4 Inhaled CS - low dose
1 5 Inhaled CS - high dose 3x3
6 Intal
7 Oral steroids
31 FOLLOW-UP APPOINTMENT: NONE / GP / MED / RESP




33 WOULD YOU RECOGNISE BAD ATTACK AGAIN
Mention - sleep disturbance
- increased BD usage







34 WHAT WDULD YOU DO? 1 Routine GP visit
2 Emergency GP call
3 Hospital "
4 Start course of steroids
5 Other
35 CURRENT Rx & MODE OF ACTION: No idea [0]/ Some [1]/ Wrong [2]
1 Inhaled B2 agonist ? S
2 Atrovent J
3 Inhaled CS i/'-
4 Intal
5 Oral steroid v/ "
6 Theophylline / oral B2 agonist
36 OTHER Rx 4- C^yJ? Lv
37 CURRENT SYMPTOMS Sleep disturbance (§)/ *ES,
Morning tightness NO /(TESj> .
Wheeze climbing 1 flight stairs CnoJ^ YES
38 Do you feel your asthma treatment is causing any side
effects? (Specify)
CODE: (j)=)None
1= Side effects appropriate to Rx
2= Side effects inapproriate to Rx
39 INHALER TECHNIQUE: (j3oodj>/ Fair / Poor
Code: 0 1 2
40 HOW IS YOUR CHEST NCW:





This form drould be ocnpletcd fcr each astlnntic patient attending
TOR TREATMFNT OF HIS ASTHMATIC OCNDITICN.
TIME INTERVAL SINCE LAST CCTEULTATTCri:
Diafjrosed at this ccnsultaticn
1-3 days
4-6 ckxys
less thfn 2 weeks
less thai 1 mcnth *"*"
I/is; thfn 6 menlit;






IS PATIENT RBOTTVIN3 grFhOID TIFRAIY?
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Management of asthma in hospital: a prospective audit
C E BUCKNALL, C ROBERTSON, F MORAN, R D STEVENSON
Abstract
In a prospective study of management of asthma in hospital
patients with acute asthma admitted to a single hospital over
a calendar year were surveyed. Altogether 157 out of 194
admissions (81%) were studied. The patients (16 of whom had
been admitted twice and one three times) were interviewed at
home about two weeks after discharge, and their hospital records
were reviewed. When interviewed an appreciable proportion of
patients said that their asthma had been poorly controlled after
their discharge from the hospital: 54 reported regular sleep
disturbance due to wheeze, 78 tightness of the chest in the
morning, and 77 wheeze after climbing one flight of stairs.
Patients had been -described on admission as having had
symptoms of deteriorating asthma for a median of three days.
Closer questioning of 71 patients, however, elicited that 50 had
had regular symptoms indicating poor control for weeks or
months. Most patients did not know how their drugs worked, and
many did not have an appropriate plan of action in the event
of a further attack. In all the cases studied 114 patients were
treated with oral corticosteroids, only 70 had had their previous
maintenance treatment increased at the time of discharge, and
107 had a follow up appointment booked for an average of three
and a half weeks after discharge.
These findings show that undersupervision and under-
treatment of patients with asthma are common and not confined
to those dying of the condition.
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Introduction
Mortality from asthma is either static1 or rising in Britain,2 with
about 2000 deaths a year. Oral and inhaled corticosteroids and
p2 agonists, which are effective in treating asthma, have not had any
impact on this figure. Several surveys of deaths from asthma have
found that some factors are preventable.55 For example, in the
British Thoracic Association's survey of deaths from asthma in
two regions of England such factors existed in 77 of 90 cases:
corticosteroids and bronchodilators were underused, patients were
poorly supervised, and both patients and doctors underestimated
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the severity of the fatal attack and delayed summoning help.5 A
leading article on asthma in Thorax in 1978 said, "in almost no other
field is the gap betweeen diagnostic and therapeutic knowledge and
its general application so great."' <
We observed in our general clinical practice that many of these
factors also applied to patients treated for acute attacks ofasthma in
hospital and sent home. A pilot retrospective survey of admissions
for asthma to our hospital during 1983 suggested that cortico¬
steroids were being underused in the management of asthma in
hospital, many patients were discharged without any change in
pre-existing treatment, and supervision of patients after the acute
attack was inadequate.7 This survey also confirmed previous reports
of resistance to use of the peak flow meter, an objective measure of
airflow obstruction.5 8
The effect of differing management regimens on outcome cannot
be studied retrospectively, nor will all cases ofasthma necessarily be
surveyed; thus we carried out a prospective audit of management of
asthma.
Patients and methods
All cases of acute asthma (and episodes of wheezing illness in non-
smokers) were identified daily by staff on the general medical wards to which
patients were admitted as emergencies. A patient in either of these categories
was approached by one of us (CEB), who explained the nature of the survey,
obtained consent to visit the patient at home about two weeks after
discharge, and obtained the agreement of the patient's general practitioner.
In the patient's home a semistructured interview lasting 20-30 minutes was
carried out, covering a check list of some 40 items. A detailed description
was obtained of the patient's history of asthma and previous treatment;
events leading up to the admission to hospital; management in hospital and
immediately after discharge; current symptoms of asthma; understanding of
the condition; and drugs given for treatment. After about two months the
case notes were reviewed and details of the severity of asthma, its
management, and supervision of the patient obtained.
Information was stored on a VAX-VMS computer and data analysed with
the statistical package for the social sciences (SPSSX).
Results
Of 194 admissions eligible for inclusion in the study, 157 (81%) were
followed up. The patients not followed up comprised three who died
(average age 66); nine transferred within 24 hours to an adjacent chest unit;
nine not seen at home as arranged (who failed to respond to a follow up
telephone call or letter); four from outside Glasgow; one whose general
practitioner refused permission for the study; one confused with coexisting
cerebrovascular disease; one transferred to long term geriatric care; three
who were readmitted to other hospitals before interview; and two vagrants
admitted on six occasions largely for social reasons. Six patients who were
interviewed but were found subsequently to have evidence in their case notes
excluding reversibility of their airflow obstruction (usually details of a
negative result of a trial of steroids) were excluded from the study.
Admissions of 139 patients over a full calendar year were investigated.
Sixteen patients were admitted twice and one three times (157 admissions).
The average age of the patients was 47 9 (SD 19-9) years. Altogether 70%
were non-smokers.
The patients' hospital records were augmented by review of records from
the asthma clinic to corroborate the diagnosis ofasthma made by the team on
the admitting ward. In all, 97 patients had objective evidence of reversible
airflow obstruction (77 had a clear history and in 20 with a doubtful history a
trial of steroids had yielded a positive result). A further 38 were lifelong
non-smokers with a clear history of'episodic wheeze typical of asthma.
Eighteen had a doubtful history of wheeze and no data on lung function.
Notes were not available for four patients.
In 141 admissions (90%) the patients had received treatment for their
asthma before admission to hospital, inhaled p2 agonists being the com¬
monest (133 patients). Of the 96 patients taking long term treatment, two
took sodium cromoglycate alone, one sodium cromoglycate and oral
steroids, six oral steroids alone, 34 oral and inhaled steroids, and 53 inhaled
steroids alone. Of the 90 taking either regular inhaled steroids or sodium
cromoglycate, 29 remembered to take the full daily dose less than five times a
week. Only 21 patients had an arrangement to start oral corticosteroids if
their asthma deteriorated, with an average starting dose of 31 mg (range
5-60 mg). Fifty one had had a sudden, severe attack (developing within one
hour, not helped by inhalers, and requiring medical attention) within the
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past three years. The median number ofprevious admissions to hospital with
asthma was one (range 0-50, with 12 patients recalling an undefined large
number ofadmissions). The median number ofvisits to general practitioners
in the preceding year for exacerbations of asthmatic symptoms was three
(range 0-12, four patients recalling an undefined large number of visits).
Fifty six patients attended a hospital asthma clinic, 41 attended their general
practitioner regularly, and some of these patients attended both.
EVENTS LEADING TO HOSPITAL ADMISSION
On interview patients reported that their asthma had deteriorated over a
median of three days (range 0-42) before admission; 56 said that their
symptoms had deteriorated over less than 24 hours. In the hospital's case
notes deterioration over a median of three days (range 0-42) was recorded in
139 cases; for the remaining 18 deterioration for "weeks" before admission
was recorded. On close questioning many patients disclosed that their
asthma had been poorly controlled for a long time and that initially they
had described deterioration that had been the "final straw.'" This was
formally assessed in the final 71 patients interviewed: 21 had had episodic
symptoms, but the others had had regular symptoms of poor control, seven
patients for weeks and 43 for months before being admitted to hospital.
Seventy patients had sought help from their general practitioners at the
onset of the episode leading to admission to hospital, and for 64 of these some
change in treatment had been made; 42 had been given antibiotics, 28 a
course of oral corticosteroids, and 11 oral bronchodilators. Immediately
before admission 87 patients had been seen by either their regular or an
emergency general practitioner, who treated 44, most commonly with
intravenous aminophylline.
ASSESSMENT AND MANAGEMENT IN HOSPITAL
Review of case records showed that the average pulse rate on admission to
hospital was 110 (SD 19) beats/minute and that 68 patients had a pulse rate
over 110 beats/minute. Only 20 had peak flow rate recorded as part of the
initial assessment, though subsequent recordings were made for 84 patients.
Arterial gases were analysed in 117 patients, of whom 44 had an oxygen
pressure of less than 8 kPa.
All patients used nebulised bronchodilators regularly during their stay in
hospital. Oral corticosteroids were given to 114 patients and 32 did not
receive any steroids. When steroids were to be continued after discharge
(110 cases) the average daily dose of prednisolone on discharge was 18 mg.
Forty seven patients were given aminophylline and 96 antibiotics. Of94 who
received oxygen, only 25 were treated with high flow (at least 35%) oxygen.
At interview 97 patients reported that their use of an inhaler had been
checked in hospital but only 32 recalled being given some explanation of
their drug treatment. Fifty one patients said that their treatment had not
been changed on discharge, and this was confirmed from their case records.
The dose of oral or inhaled drugs, or both, had been reduced for 30 patients.
Hospital review was planned for 107 cases, to take place an average of 3'5
(SD 2 0) weeks later.
The diagnosis of acute asthma was recorded on the discharge summaries
for only 83 of the 157 cases (53%), even though the medical and nursing staff
reported all these patients to us as having asthma. In 135 (86%) cases a
diagnosis of reversible airflow obstruction or episodic wheeze in lifelong
non-smokers had been recorded previously. In two cases the diagnosis
was asthma and bronchitis, and in 46 it was exacerbation of chronic
obstruction airways disease. Various other diagnoses were recorded for nine
patients and none for 12; notes were not available for five.
PATIENTS' UNDERSTANDING OF THEIR ASTHMA AND TREATMENT
As an earlier interview may influence patients' subsequent understanding
of their drug treatment we assessed only first admissions (n=139) in this
section. One hundred and thirteen patients thought that they would
recognise a bad attack of asthma in the future, usually on the non-specific
basis of increasing wheeze and tightness of the chest. Only 10 patients
spontaneously mentioned sleep disturbance, six increased use of broncho¬
dilators, and 18 decreasing efficacy of inhaled bronchodilators as specific
signs of worsening asthma. Eighty seven patients said that they would either
call their doctor in an emergency or, depending on the severity of the attack,
go straight to hospital, but 47 had no appropriate plan of action for a further
attack. On specific questioning 21 said that they had arrangements to start a
course of oral steroids, but only two volunteered that this would be their
response to a further attack.
The table shows the numbers of patients taking drugs when interviewed.
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Patients' understanding of treatment of their asthma
No (%) of those taking drug with:
No (%)
taking drug Some idea of No idea of Wrong idea of
Category of drug (n= 139) actionofdrug actionofdrug action of drug
(i2 Agonists:
Inhaled 131(94) 54(41) 73(56) 4(3)
Oral or theophylline 62(45) 11(18) 51(82)
Corticosteroids:
Inhaled 100(72) 32(32) 61(61) 7(7)
Oral* 65 (47) 7(11) 55 (85) 3(5)
Ipratropium 23(17) 8(35) 15 (65)
Sodium cromoglycate 3 (2) 1(33) 2(66)
•Includes some patients finishing a short course of oral steroids.
Most had no idea how their drugs worked, in particular whether they were
quick acting or had a long term effect.
CONTROL OF ASTHMA AFTER DISCHARGE FROM HOSPITAL
Regular sleep disturbance after their discharge from hospital was reported
by 54 patients, regular tightness of the chest requiring them to use their
bronchodilator before rising from bed by 78, and wheeze on climbing one
flight of stairs by 77. Analysis with the x2 test of the 62 patients who reported
no sleep disturbance or tightness of the chest in the morning and the
95 patients who did showed these two groups to be broadly similar in age and
severity of previous asthma. Significantly more patients without symptoms
(■/2=6'4, df= 1, p<001) had been looked after in general medical wards with
an interest in respiratory diseases.
Discussion
This is the first prospective survey of management of asthma in
hospital to be reported and included 81% of all admissions for
asthma to a single hospital over a calendar year. Assessments were
performed in the patients' homes by a physician with experience of
managing asthma. Most of the patients had clear histories, and most
had objective evidence of reversible airflow obstruction and could
be clearly differentiated from patients with an exacerbation of
chronic bronchitis with minor wheeze. They had moderately
severe asthma, with 61% receiving long term inhaled or oral
corticosteroids. In this respect they were broadly similar to the
patients in the British Thoracic Association's study, 62 (69%) of
whom had been receiving such treatment.5
Several characteristics of the patients deserve mention. Only 13%
had been instructed to start taking oral steroids if another severe
attack occurred but only 1% mentioned steroids when specifically
asked what they would do in a severe attack. Only a few patients had
peak flow meters to use at home, although 32% gave a history of
sudden severe attacks. Compliance of patients was judged to be fair.
Less than half had been to see their general practitioner during the
index attack; a common reaction of patients was that such attacks
had to be tolerated and would settle with time. Indeed, 34% had no
appropriate plan of action in the event of a further attack. Most
patients had little understanding of the way in which their drugs
could be expected to help them. These findings are similar to those
of a survey of patients at an asthma clinic in Aberdeen10 and enlarge
the finding of the British Thoracic Association that patients dying of
asthma underestimated their disease and delayed calling help.5
Forty per cent of those who saw their practitioner were given
steroids before admission to hospital and 80% received them in
hospital. Instructions about dosage after discharge seemed to have
been adequate, but corrective and maintenance treatment may have
been inadequate as a large proportion of patients had nocturnal and
early morning asthma and reduced exercise capacity at interview.
A retrospective survey of management of asthma in hospitals
has shown differences between general physicians and those
specialising in diseases of the chest." Significantly more of our
patients who did not have symptoms of asthma at interview had
been managed in medical wards with an interest in respiratory
diseases. This finding, more fully documented elsewhere,12 suggests
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that corrective and long term treatment may be better in sucl
wards.
Both general and hospital practitioners continue to be pre
occupied with bacterial infection in asthma: 66% of patients wer<
given antibiotics at home and 61% in hospital despite good evidenct
that such treatment has no effect on the duration and severity of ar
attack of asthma." Only a small proportion of patients were treatec
with high flow oxygen (27% of those receiving oxygen), and very few
had peak flow measured as part of their initial assessment.
The previous regular treatment in 51% of cases was unalterec
or even reduced after discharge from hospital. The median duratior
of increasing symptoms recorded in hospital was three days
whereas 70% ofpatients admitted on direct questioning to symptom:
of poor control for weeks or months before admission. These
findings suggest that an inappropriately short term view of the
illness was being taken. The time to follow up—an average of three
and a halfweeks for those patients given appointments—disregard:
the possibility of symptoms recurring as the dose of oral steroids i:
decreased.
This study shows that asthma is often poorly treated in general
medical units, with inadequate attention being paid to the im¬
portance of pre-existing poor control, to improvement of lung
function and treatment, and to the continuing close supervision of
patients in an unstable phase of their disease. Management is
individual both to patients and, to some extent, to physicians. Broad-
generalities do, however, exist, and most physicians specialising in
respiratory diseases would agree that acute asthma should be treated*
with high flow oxygen, nebulised bronchodilators, and oraf
corticosteroids and that peak flow measurements provide an
important objective measurement of airflow obstruction.14
Comparisons are sometimes made between asthma and diabetes
in the chronicity of disease and in treatment. Patients need to
understand their condition and be able to react appropriately.
This survey shows that the management of asthma, however, is
often a reaction to'the extreme event of status asthmaticus, and the
idea of fine tuning of asthma control to achieve the respiratory
equivalent of normoglycaemia is almost entirely neglected.
Long term undertreatment and undersupervision have been
identified as the most important factors in preventing deaths from
asthma. Our survey shows that such suboptimal management
practices are common even in hospital, where a high awareness of
modern treatment would be expected. We believe that extrapolation
of these results might explain the apparent failure of new and
effective drug treatments to reduce the mortality from asthma.
We acknowledge the support of the medical and nursing staff of the
medical wards, especially those who received acute medical admissions; the
patients who gave their time; and Irene Adams, who processed the
manuscript.
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Summary Asthma management was audited
prospectively for one year in a large
teaching hospital. Full details were available on 77% of all
patients admitted, or readmitted, with asthma during that
year (150 of 195 admissions). 64 patients were admitted to
general wards with a special interest in respiratory medicine,
and 86 to general wards without this specialist interest.
Cases in the two groups were similar in terms of age,
previous severity of asthma, previous treatment, and initial
pulse rate. Fewer cases in the non-specialist group were
treated with oral corticosteroids (67%, vs 83%), had regular
peak flow recordings (42%, vs 73%), or were given return
appointments (56%, vs 92%); and fewer had their regular
inhaled therapy increased after discharge (28%, vs 55 %). At
interview 13 days later, more patients from the non-
specialist group reported sleep disturbance (41 %, vs 23%),
morning chest tightness (55%, vs 37%), or wheeze on 1
flight ofstairs (58%, vs 34%). 20% offirst admissions in the
non-specialist group were readmitted within the year,
compared to 2% of the group treated on wards with a
specialist interest in respiratory medicine. These data
suggest that the intensive management of asthmatic
patients, practised in respiratory units, prevents much
unnecessary morbidity.
introduction
DIFFERENCES in asthma mortality rates between
specialist thoracic and general medical units have been
known for ten years.13 A retrospective sample of asthma
cases cared for in thoracic and general units in 1978 showed
that respiratory physicians used more objective
measurements ofdisease severity and of response to therapy,
and prescribed inhaled drugs after hospital discharge more
often than general physicians.1
Asthma mortality rates in the UK may be static,5 or
increasing6—but the mortality rates have not fallen over the
past 20 years, despite major advances in therapy. However,
evidence from national morbidity surveys in general
practice suggests that the annual period prevalence of
asthma is rising,7 and Hay and Higenbottam have suggested
that asthma morbidity is declining owing to the greater use
of inhaled corticosteroids and sodium cromoglycate.8
We report on a prospective survey of hospital asthma
management in which we were able to assess the
management, supervision, and outcome of patients looked
after by general medical units with, and without, a specialist
respiratory interest.
patients and methods
The Glasgow Royal Infirmary has 4 general medical units which
receive emergency medical admissions on a 1 in 4 daily rotation. 2 of
these units have a specialist respiratory physician on the staff.
Between June 1, 1985, and May 31, 1986, patients who were
admitted with acute asthma, or non-smokers with episodes of
Group R Group G
— n = 64 n = 86
Average age, yr (SD)* 44-3 (18-7) 50-6 (20-4)
Diagnostic category:
Patients in groups i + ii 49 (77%) 63 (73%)
Patients in group iii 7(11%) 11 (13%)
Patients in group iv 8(12%) 12 (14%)
% Smokers (non-, ex-)* 31% (39,30%) 28% (44,28%)
Patients on steroids—any form—
before admission 35 (60%) 55 (64%)
Previous hospital admissions (SD)* 3-0 (7-7) 3-9 (81)
Exacerbations in past yr (SD)* 3-5 (5-4) 3-9 (3-9)
Length of exacerbation before
admission, d (SD) 5-1 (5-4) 3-9 (4-9)
Initial pulse rate, beats/min (SD) 109 (181) 111 (20-6)
*Based on first admission only.
wheezing illness, who were reported by the admitting firm, were
included in a prospective survey of the management that they
received in hospital and after discharge, and its effect on their
symptoms after discharge. Patients were approached during their
stay in hospital by one of us (C. E. B.), who obtained permission to
visit them at home 2 wk after discharge—with no further
involvement in their management, or knowledge of their treatment.
At the home interview, a record was taken of the patient's asthma
history, previous treatment, events leading up to the last admission,
drug treatment and symptoms after discharge from hospital, and
their understanding of the condition and medications. After a
further 2 mo, the hospital case notes were reviewed and details of the
management and supervision of the hospital admission were
obtained.
The certainty with which a diagnosis of asthma could be made
varied from patient to patient. We defined 4 categories:
i. Patients with a clear history of episodic wheeze and pulmonary
function tests showing reversible airflow obstruction, whether
smokers or non-smokers.
ii. Patients with a clear history of episodic wheeze, but without
records of pulmonary function, who were lifelong non-smokers.
iii. Patients with a less certain history of wheeze, but who had
pulmonary function tests showing evidence of reversible airflow
obstruction; most of this group were smokers or ex-smokers.
iv. Patients with a less certain history of wheeze, and no
pulmonary function test results; most of these were smokers or
ex-smokers.
Data were stored on a VAX-VMS computer and further analysis
was made by use of SPSS-X. Chi-squared analysis was used to test
the null hypothesis that there was no difference between the two
groups. A small, non-significant difference in age was observed
between patients admitted in the two groups: because of this, a
case-control analysis was also performed. Pairs of patients were
matched between the two groups, and results were analysed as
described by Breslow and Day.9
results
195 patients with symptoms appropriate for inclusion into
the study were admitted during the year, but only 157 cases
were interviewed at home, of whom full details were
available on 150 (77%). We have no reason to suspect that
the other patients were unrepresentative; full details of the
trial protocol will appear elsewhere (Bucknall CE, et al. Br
MedJ. (In press).
64 patients were admitted to general wards with an
interest in respiratory medicine (group R), and 86 patients
(57%) to general wards without this specialist interest
(group G). The two groups of patients were similar: 47% of
each were males, and no significant difference was observed
for diagnostic category, or other variables as shown in table i.
Differences in diagnosis, management, and supervision
within hospital are shown in table ii. Differences in
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permitted additives, for example; these include "immortelle
absolute", a product promising more than it can deliver. In
1983 the committee had been wary of the claim that passive
smoking was associated with lung cancer. No longer: they
now conclude, along with the US Surgeon General and
others, that the risk is real. The rate of lung cancer in
non-smokers rises by 10-30% on regular exposure to other
people's smoke. Whether this increase is "small" or not, it
means that the annual incidence in non-smokers aged 35 or
more would rise from 10 to 11-13 per 100 000. The range
may reflect current British expert opinion on the matter6 7
but it seems generally acceptable. To this burden other
health effects must surely be added.
The Government, no enemy of the tobacco barons, sees
the report as reflecting "established policies of voluntary
arrangements". Not everyone is so content with those
arrangements, not even the chairman of the committee
which monitors them.8 Nor is Sir Peter, who disburses, via a
controversial trust, up to £1 million of tobacco money per
annum. The voluntary agreements stop him supporting all
the research he would like to.
IS ROUTINE URINALYSIS WORTHWHILE?
Urinalysis and urine microscopy have become
accepted as an essential part of clinical assessment; until
lately, the value of their routine use in all new patients had
not been questioned publicly. Private doubts about the
value of routine microscopy are manifested by the difficulty
in finding a functioning microscope in wards other than
those devoted to urology or nephrology. Urinalysis, which is
usually undertaken by the clinic nurse and therefore
occupies no medical time, has not been subject to the same
pressures and therefore survives in most hospital patient
assessments. When urinalysis and microscopy are
specifically indicated by the patient's history or the findings
on examination the yield of information is high and the value
ofurine testing is not questioned.1 However, it has now been
suggested that the yield from routine testing in patients
without specific indication is low and insufficient to justify
the not inconsiderable expense.1-2 At first sight, it may seem
that the cost of screening is negligible since the appropriate
dipstick costs only about 9 pence and unstained bright-field
microscopy takes no more than a few minutes of physician
time. More careful analysis suggests that the true cost in UK
may not be very different from the American figure of $22
per test,1 since collection and testing of urine specimens has
been shown to occupy 6-5% of a district nurse's time,3 and
preparing a specimen for microscopic examination takes
several minutes ofa physician's time. Thus, there is a case to
answer—is the cost worthwhile?
The major argument against routine testing is the
observation1-2 that although abnormalities are found in
approximately a third of tests, the therapeutic yield is very
small, leading to change of treatment in only 1-2% of
6. Wald NJ, Nanchatal K, Thompson J, Cuckle H. Does breathing other people's
tobacco smoke cause lung cancer? Br MedJ 1986; 293:1217-21.
7. Peto J, Doll R. Passive smoking. BrJ Cancer 1986; 54: 381-83.
8. Committee for Monitoring Agreements on Tobacco Advertising and Sponsorship.
First report. London: HM Stationery Office, 1988.
1. Akin BV, Hubbell FA, Frye EB, Rucker L, Friis R. Efficacy of the routine admission
urinalysis. Am J Med 1987; 82: 719-22.
2. Kroenke K, Hanley JF, Copley JB, et al. The admission urinalysis: impact on patient
care. J Gen Intern Med 1986; 1: 238-42.
3. Pritchard PMM. Manual of primary health care. Oxford: Oxford University Press,
1978: 32.
patients. Moreover, initially abnormal tests that
subsequently reverted to normal could lead to additional
investigations which are expensive and potentially
hazardous. Two assumptions in this argument should be
challenged. The first is that it is possible to separate by
means of the average clinical history and examination, in as
reliable way as did the panel of experts in the study by Akin
et al,1 patients in whom urinalysis was indicated for
diagnostic purposes (high yield) from those in whom it was
not (routine testing, low yield). Surely in clinical practice it is
better to do urinalysis in all patients as a double check against
having missed a clue to a relevant disease in the history or
examination. The second assumption is that the discovery of
an abnormality is of no importance if it does not lead to
useful corrective treatment. Whilst it may be true that
symptomless urinary tract infection should not be treated,
knowledge of its presence may be useful in guiding future
treatment or as an indication for further investigation or
follow-up. Similarly, there may be no curative treatment for
glomerulonephritis, but control ofhypertension is probably
valuable in slowing progression of renal damage;4 detection
of proteinuria or haematuria is therefore useful in selecting
patients who require long-term surveillance even if the
severity of the haematuria or proteinuria is not itself
considered sufficient to warrant renal biopsy.
Whatever the pros and cons ofurinalysis and microscopy,
its survival in a particular doctor's routine practice will
depend on the yield he sees in his patients. In patients
admitted to a general medical ward it is likely to be high:
Akin and colleagues1 found abnormalities in 57%. In the
general population it is much lower: 2-5% of men
undergoing routine health screening were found to have
haematuria;5 approximately 5% of women of childbearing
age have significant bacteriuria;6 and proteinuria is present
in 0-6-5-8% ofadults7 and diabetes in about 1-3%.8 Overall,
in a survey of patients in general practice, 11 % ofmales and
18% of females had urinary abnormalities,10 most of which
were detected by urinalysis rather than microscopy.
Thus the prevalence of urinary abnormalities is
sufficiently high to justify routine urinalysis both in hospital
and in general practice, although it must be remembered
that abnormal findings should be confirmed before further
investigation is undertaken. What about a crusade for
routine screening microscopy? The answer is probably not.
It has been suggested that ". . . microscopic urinalysis be
omitted if the macroscopic urinalysis to include normal
colour, clarity and reagent-strip testing is negative in an
asymptomatic individual";11 this seems a reasonable
compromise in view of the small probability of missing an
important abnormality in such patients. The crusade should
be to persuade doctors to carry out urine microscopy in
patients in whom it is indicated.
4. Baldwin DS, Neugarten J. Blood pressure control and progression of renal
insufficiency. In: Mitch WE, Brenner BM, Stein JH, eds. The progressive nature
of renal disease. New York: Churchill Livingstone, 1986: 81-110.
5. Ritchie CD, Bevan EA, Collier SJ. Importance of occult haematuria found at
screening. Br MedJ 1986; 292: 681 83.
6. Kass EH, Savage W, Santamarina BAG. The significance of bacteriuria in preventive
medicine. In: Kass EH, ed. Progress in pyelonephritis. Philadelphia: FA Davis,
1965.
7. Evans DA, Williams DN, Laughlin LW, et al. Bacteriuria in a population based cohort
of women. J Infect Dis 1978; 138: 768-73.
8. Chavers BM, Vernier RL. Proteinuria and enzymuria. Sem Nephrol 1986; 6: 371-88.
9. College of General Practitioners. A diabetes survey. Br MedJ 1962; i: 1497-1503.
10. Elliott P. Experience of urine screening in general practice. Focus on urine analysis.
Oxford: Medicine Publishing Foundation, 1983: 33-35.
11. Schumann GB, Greenberg NF. Usefulness of macroscopic urinalysis as a screening
procedure. A preliminary report. Am J Clin Pathol 1979; 71:452-56.
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TABLE II—HOSPITAL DIAGNOSIS, MANAGEMENT, AND
SUPERVISION
Group R Group G 95% Confidence
— n = 64 n = 86 Intervals
Treatment in hospital (%):
Oral corticosteroids 53 (83) 58 (67)* 2-5%, 29-5%
Antibiotics 35 (55) 61(71) -31-5%, 0%
Aminophylline 20(31) 25 (29) —
Supervision (%):
PEFR ± spirometry 47 (73) 36 (42)t 15-9%, 46-1%
Blood gas analysis 50 (78) 65 (76) —
Inhaler technique assessed 46(72) 45 (52)* 6-2%, 33-8%
Explanation of drug action 18 (28) 12 (14)* —
Diagnosis at Discharge (%):
Asthma 41 (64) 43 (50) —
COAD 10(16) 36 (42)t -39-8%, —12-2%
Other 13 (20) 9(10) —
*p <0-05; tp< 0-005.
treatment, supervision, and outcome on discharge from
hospital are shown in tables III and IV. Cases in group R were
significantly more likely to be treated with oral
corticosteroids, and to have peak flow rates or spirometry
monitored (p < 0.005). No difference in the frequency of
arterial blood analyses was observed. Significantly more
cases in group R had inhaler technique checked, although no
difference in the proportions of patients judged to have
either good or fair inhaler technique was found at the
interview. More cases in group R remembered being given
some explanation of the action ofdrugs prescribed. A highly
significant difference (p< 0-005) was found between
proportions of cases with no planned review appointments.
No differences between the groups were seen for changes in
oral therapy after discharge, but a greater proportion ofcases
in group R had inhaled therapy increased at the time of
discharge (p <0.005). The differences in management
between the two groups were associated with significantly
fewer asthmatic symptoms reported by group R (table IV).
17 patients had more than one admission to hospital with
acute asthma during the year: 15 (88%) of these were first
admitted to medical wards with no specialist respiratory
interest (group G): thus 20% ofcases first admitted to group
G were readmitted to hospital within the year, compared
with 2% for group R (p < 0-005).
A highly significant difference (p < 0-005) was seen in the
proportions of cases described as acute asthma or an
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Oral corticosteroids given 15, 5 <0-05
Lung function monitored 19, 4 <0-005
Admissions diagnosed as asthma, vs COAD 12, 2 <0 005
Sleep disturbance at interview 5,17 <0-025
Morning chest tightness 6,16 = 0.06
Wheeze on 1 flight of stairs 7,19 <0-05
Clinic review planned 24, 4 <0-0005
The first number gives pairs with the variable present in group R but not in
group G; the second gives pairs with the variable present in G but not R.
(Thus in 15 pairs oral corticosteroids were given to the patient in R, but not to
the corresponding matched patient in G; in 5 pairs they were given to the
patient in G but not to the one in R; in the other 31 pairs both patients received
the same treatment.)
exacerbation of chronic obstructive airways disease
(COAD) (table II), despite the fact that all cases were initially
reported as acute asthma or wheezing illness in non-
smokers. In addition, the proportions of cases in the various
categories ofdiagnostic certainty for asthma were similar for
the two groups (table I), suggesting that these diagnoses
were being used indiscriminately in group G.
In view of the small, though non-significant, difference in
age between the two groups, with older patients in group G,
cases admitted to group R were matched with suitable group
G cases, that allowed an analysis of 51 matched pairs to be
made (68% of the sample). The results of this case-control
analysis confirm the previous findings: differences between
the two groups remained significant except that there was no
discordance between pairs in terms of increases in inhaled
treatment at discharge, or of morning chest tightness at
interview (table V).
DISCUSSION
This survey shows major differences in the management
of asthma between units with and without a specialist
respiratory interest, and that these differences affect
outcome. Differences in mortality rates have been
commented on in previous surveys of hospital asthma
deaths23 and differences in management in a retrospective
sample of asthma admissions,4 but no prospective survey of
asthma admissions has previously been reported. The
findings ofOsman et al4 are strikingly similar to our own: the
passage of 7 years has apparently had little effect on poor
asthma management practices.
The cases represent 77% of all acute asthma admissions
over a calendar year, the majority having objective evidence
of reversible airflow obstruction in addition to histories of
episodic wheeze. They can be clearly distinguished from
cases of chronic bronchitis with mild associated wheeze: it is
disturbing, therefore, that general medical units appear to be
reluctant to make a positive diagnosis ofasthma. Speight and
co-workers10 surveyed school children with asthma and
found that a failure to use the term asthma was associated
with underuse of specific asthma treatment. Our findings
suggest that use of the label COAD, rather than asthma, is
particularly associated with differences in supervision in
hospital and after discharge, although the lesser use of oral
corticosteroids in non-respiratory medical units applied
both to those labelled asthma and COAD. Non-respiratory
medical units are less inclined to use peak flow recordings,
and we also found a high proportion of cases discharged
without follow-up appointments. These differences are
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associated with a significant excess of short and long term
morbidity, with more patients reporting symptoms of poor
asthma control soon after discharge, and more readmitted to
hospital within the year.
This survey provides unequivocal evidence that asthma is
often poorly managed in hospital, and that such poor
management practices, which may occasionally contribute
to death,11 are the cause of a great deal of preventable
morbidity. Ten years have passed since the management of
asthma in general medical units was called into question: the
answers are known, but have yet to be generally applied.
We thank the medical and nursing staff of the medical unit and the patients
for their cooperation, and Miss Irene Adams for secretarial assistance.
Correspondence should be addressed to C. E. B., Govan Health Centre,
295 Langlands Road, Glasgow G51 4BJ.
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Summary Two panels ofdoctors, one in the USA and
one in the UK, were asked to indicate how
appropriate they judged a series of possible indications for
coronary angiography and coronary artery bypass graft
(CABG) operations. "Appropriateness" was defined with
respect to possible benefit to the patient and excluded
considerations of cost. The indications were presented as a
series of detailed clinical situations in which the procedure
might be used, and for each indication individual panel
members rated appropriateness on a scale of 1 to 9. The US
panel judged more indications appropriate than did the UK
panel, and there was more agreement among the members of
the US panel than among those of the UK panel. Although
the two panels tended to rate the appropriateness of the
indications in the same order, the UK panel placed more
emphasis than did the US panel on the importance of
symptoms and the amount of medical treatment.
Application of the panels' ratings to two groups of patients
who had had coronary angiography showed that 17% and
27% of the investigations had been inappropriate by the
standards of the US panel, whereas 42% and 60% were
inappropriate by the UK panel ratings. 13% of the CABG
operations studied were inappropriate by the US and 35%
by the UK panel ratings.
introduction
Spending on health care differs widely in the developed
world, and some of the largest differences are found between
the USA and the UK. For example, in 1985 the rate of
coronary artery bypass graft (CABG) operations per million
population was 1000 in the USA and 210 in the UK (ref 1
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and Trent Regional Health Authority, unpublished). This
disparity cannot be explained by differences in the
prevalence of coronary disease in the two countries, and
whether the operation is overused in the USA or underused
in the UK is not clear. Do doctors in the two countries have a
different perception of the value of the operation to the
patient or does the difference in CABG rate reflect the
availability of resources? To explore the difference in the use
of coronary angiography and CABG in the USA and the
UK we have examined the attitudes of panels of physicians
and surgeons from the two countries. We have used our
findings to assess whether the use of these procedures was
appropriate in three groups of American patients.
methods
Assessment of Appropriateness
We developed "appropriateness ratings" for possible clinical
indications for coronary angiography and CABG. From published
work we assessed the circumstances in which each procedure had
proved effective and we took account of its risk.2-3 From this review
and from discussions with clinicians, we devised for both coronary
angiography and CABG a comprehensive series of clinical
situations (brief case histories) in which the use of each procedure
might be considered. Patients were categorised according to
hypothetical clinical situations or indications with respect to
symptoms, past medical history, medical treatment, and the results
of investigations. In each case, the information was detailed enough
that patients with the possible indication could be seen to be
reasonably homogeneous and the procedure would be equally
appropriate (or inappropriate) for all of them. The list of case
histories included all the possible indications that might arise in
practice, but was short enough to allow the panelists to score their
ratings of appropriateness within a reasonable time.
The possible indications for each procedure were organised
according to clinical settings in which the procedure might be used;
in most cases these corresponded to major symptoms such as those
seen in chronic stable angina or to clinical situations such as those
arising after acute myocardial infarction. Within each clinical
setting we created possible indications by permuting factors such as
the severity ofangina, the degree ofmedical therapy, and the results
of exercise tests; thus 300 possible indications for coronary
angiography and 480 for CABG were devised. Table I shows
examples ofthe case histories; a complete list of these indications has
been published elsewhere.2-3
In each country, we convened a panel of doctors to rate the
possible indications. Each panel used the same 9-point scale of
appropriateness, where 9= highly appropriate, 5 = equivocal, and
1 = highly inappropriate. We defined appropriateness as the extent
to which the perceived benefit of a procedure exceeds the expected
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are
only
useful
if
you
also
have
an
attack
of
bronchitis.Remember
—
bad
attacks
of
asthma
don't
happen
suddenly,
they
usually
build
up
over
a
period
of
days
or
weeks,
and
can
be
prevented
if
you
know
what
to
look
out
for,
and
what
to
do.
In
the
long
term
steroids
are
sometimes
used
in
a
small
daily
morning
dose
IN
ADDITION
to
a
steroid
inhaler
(e.g
Becotide
or
Becloforte)
if
the
inhaler
alone
is
not
enough
to
control
symptoms.
It
is
important
to
keep
using
the
inhaler,
to
keep
the
tablet
dose
low
and
so
prevent
side
effects.
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